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ABSTRACT 
Quality end of life (EOL) care for the elderly continues to be a challenge, in part 
due to late referral for palliative and/or hospice services. The purpose of this study was to 
determine the accuracy of the MDS-CHESS scale (Hirdes, Frijters & Teare, 2003) in 
predicting 6-month mortality in a stable American nursing home (NH) population. A 
secondary aim was to determine any differences in mortality between the 2 sites. 
A sample of 191 residents of two NHs was analyzed in a retrospective, 
correlational cohort study, using data collected from the federal MDS database. 
Correlational statistics and logistic regression were utilized to determine relationships 
between predictive variables, and to examine the overall quality of the regression model. 
The items that comprise the MDS-CHESS scale (DNR status, daily pain, IV site, IV 
medications, oxygen, suctioning, Physician's visits, Physician's orders and abnormal 
labs) demonstrated weak relationships among some of variables, although p-values were 
significant. 
The predictive model was analyzed on a final sample of 81 subjects who died 
during the evaluation period. Regression coefficients were generally low (range 0.09-
0.46) and none demonstrated significance in the likelihood ratio test. Odds ratios were 
uniformly low (range 0.52-2.26) as well. Differences between the 2 NH were negligible 
in the correlational analysis, as well as the logistic regression statistics and overall 
mortality. 
This study examined the accuracy of the MDS-CHESS scale in predicting death 
in a cohort of NH residents, and determined differences between the two NH. Early 
identification of elderly NH residents at risk of dying can improve the quality of care by 
promoting palliative care and hospice referral in a timely manner. Reduction of suffering 
through determination of goals of care and appropriate therapeutic interventions remains 
an important priority in all settings. 
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Overview of the Problem 
The Institute of Medicine (IOM) report, Approaching Death: Improving Care at 
the End of Life (1997) created ripples of thought and action in healthcare when it was 
published. This monograph was the first comprehensive summary of end of life (EOL) 
practices, perceptions and recommendations that detailed how Americans experienced 
debility and decline prior to death. The report identified gaps in health care and 
community support for elders and others dealing with life-limiting illness. Although the 
hospice movement was well established in America by that time, curative treatment 
remained the standard of care for people with serious, life-limiting illness. 
The Last Acts Coalition report, Means to a Better End (2002) examined 
regulatory directives and laws throughout America, as well as EOL practices in a variety 
of healthcare settings. Of particular note in this report was the significant lack of 
adequate EOL care in nursing homes (NH). Health care professionals and people in 
mainstream America were beginning to openly confront the idea that dying is a part of 
life and failure to discuss personal wishes with loved ones creates profound problems and 
an avoidable burden of decision making during times of emotional stress. 
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As clinical, legal and ethical experts contributed to the knowledge base through 
publications and presentations at professional conferences, as well as recommendations 
to government organizations, momentum grew to create a vision for improving care of 
the dying in all healthcare and community settings. Several consensus reports followed 
the IOM report that broadened the scope of understanding of different aspects of care of 
people with terminal and life-limiting illness, and made recommendations for future 
action and research (Describing Death in America, 2003). 
In subsequent years, much progress has been made in America with regard to 
discussion of EOL wishes and understanding of the dying process. Regulatory 
requirements have increased inquiries regarding Advanced Directives when people are 
hospitalized (Hawes et al., 1997). Social movements and non-profit organizations have 
successfully raised awareness of the importance of discussing end of life wishes and 
identification of alternate decision-makers. Less common is a discussion of quantity 
versus quality of life. Medical advances have resulted in many fatal illnesses (e.g. cancer, 
renal failure) becoming chronic diseases. As functionality decreases over time, treatment 
morbidity increases. Organ damage, fatigue and psychological alterations become part of 
the everyday life, requiring additional medications and interventions. Yet, too seldom is 
there a discussion between physician and patient that presents treatment withdrawal with 
aggressive comfort management as the best option for care. 
There are many reasons for this deficit; among them is the difficulty in predicting 
with accuracy an estimated time left to live. Withdrawal of treatment is often seen as a 
failure by the physician and by the patient as abandonment (Christakis, 1999a). Failure to 
promote the option of aggressive supportive care during the terminal phase of illness 
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influences the decision to continue futile, aggressive treatment. People fear pain, 
suffering and abandonment. Although healthcare professionals cannot guarantee freedom 
from symptoms or loss of function, physical, emotional and spiritual support is available 
that can ease the transition into the terminal phase of illness. The availability of 
gerontology specialists has also improved NH care and promoted realistic expectations 
regarding decision-making and autonomy, as well as promoted the inherent value of the 
elderly. Understanding the concerns and fears of NH residents is essential to promoting 
good quality of life and self-determination. 
Improving EOL care of the elderly is a problem of immense proportions. More 
than 2.4 million Americans die each year of various causes; 1% of the GNP is spent on 
ICU care and 23% die in nursing homes (Esserman, Belkora, & Lenert, 1995). Upon 
admission to a NH, 35% will die within one year (van Dijk, et al., 2000). Less than 30% 
of Medicare patients with serious illnesses die while utilizing the hospice benefit, 
resulting in a large proportion of terminally ill people dying with poorly controlled 
symptoms (Christakis, Iwashnya & Zhang, 2002). These data point to a tremendous 
human and financial cost to patients and organizations because EOL care is not well-
managed. 
Prognostication 
The process of estimating a patient's future health status can be complex and 
intimidating not only to the novice but to the experienced physician as well. Nurses do 
not view prognostication as within the scope of their practice, yet are engaged in 
conversations with patients and families on a routine basis regarding when a loved one is 
expected to die. 
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The terms prognosis and prognostication overlap, yet are quite different in 
meaning. Stedman's Medical Dictionary (2007) defines the term prognosis as "a 
prediction of the probable course and outcome of a disease", as well as the "likelihood of 
a recovery from a disease". These definitions represent two distinctly different constructs; 
that of a prediction and outcome, and that of recovery. It is not difficult to understand the 
confusion that exists because of lack of specificity in terminology. 
Christakis (1999a) developed a more refined definition, stating that prognosis was 
an objective reality; ". . . the actual prospect of a recovery from a diagnosis given the 
nature of the disease and the special features in question." This definition is from the 
patient's perspective, and arose out of patient inquiries about severity of illness and 
possible proximity to death. Relying only on one perspective (that of the patient) 
undermines this complex process because understanding of a new clinical diagnosis 
occurs through mutual conversation, and interpretation of clinical information in the 
context of the situation. In this spirit, Christakis also defines prognosis from the 
subjective point of view as being the physician's impression of what might happen; 
" . . . the acts of foreseeing and foretelling the course and outcome of a disease" (p. 19). It 
is the physician's perception of the patient's experience. Prognostication is thought to be 
a forecast or prediction (Stedman, 2007) and is used broadly throughout the business 
world as well as in healthcare, to respond to industry changes and planning mandates. 
This definition is too simplistic and fails to acknowledge the nature of the physician-
patient relationship. Christakis deems the act of prognostication as " . . . an intellectual 
process whereby the physician moves from knowledge about disease in patients in 
general to knowledge about its expression in an individual" (Christakis, p. 20). This is an 
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important basis for subsequent communication as disease advances. If the act of 
prognostication is not done with restraint, perspective and knowledge of the limits of 
medical care, then "disrespectful overtreatment" is a risk during times of crisis 
(Christakis, p. xiv). 
Avoidance of overtreatment is a common theme of dialogue in clinicians caring 
for people with advanced illness. Many clinicians lack knowledge about how to balance 
comfort with desired goals of care. Some of the barriers to providing comfort through the 
use of hospice and palliative care services include the availability of consultation 
services, poorly identified goals of care, and difficulties with prognosis. The majority of 
NH residents are clinically stable, with multiple co-morbidities. Exacerbations and 
remissions of chronic illness are normal events and death is often sudden and unexpected, 
but not surprising. Prognostication is difficult, and few instruments can accurately predict 
death within a certain time frame. Several instruments can predict risk of complications 
or mortality if certain illnesses are present, such as the Functional Assessment Staging 
(FAST) scale for dementia (Volicer et al., 1993). However, the multiple chronic illnesses 
that are present with most NH residents might make use of such instruments less reliable. 
Several instruments are more broad-based and will be discussed in greater detail in 
Chapter Two. 
The Minimum Data Set (MDS)for Nursing Homes 
As a culture, Americans are less likely in the 21st century to care for aging loved 
ones at home. The demise of the nuclear family and economic necessity of working 
outside of the home has resulted in fewer extended families residing within the same 
home. Insufficient retirement funds prevent many elders from living independently with 
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assistance as needed. The increased availability of nursing homes (NH) in the last century 
has meant that institutional or group living is the only viable option for many sick and 
elderly people. Because of the potential for poor quality care, the NH industry has 
become highly regulated in an effort to ensure resident safety and to minimize fraud. 
Among the regulatory requirements are the routine and systematic assessment of 
NH residents, and the evaluation of quality indicators on a routine basis. To participate in 
state and federal Medicare reimbursement programs, NHs must collect resident data and 
submit it to a federal database for analysis. Reports are returned to the NH after several 
months, care deficits are identified and improvement plans created. Many researchers 
have utilized the Minimum Data Set (MDS) database to conduct research on the care of 
NH residents and identify trends within certain geographic areas. The information 
collected for submission to the MDS database provides a valuable sample with adequate 
power to demonstrate statistical significance. The MDS is the database from which the 
sample was derived for this study. 
Conceptual Framework 
A long-standing problem with healthcare is the gap between research and clinical 
practice. Clinicians lack the time to absorb research advances, and it has only been in the 
past decade that researchers are beginning to partner with clinicians to implement and 
evaluate evidence-based practices outside of pharmaceutical studies. The advent of large 
national administrative databases has facilitated the refinement of health outcomes 
research design, however, the process is slow and many barriers exist for implementation 
of novel tools for quality improvement. One driving force that is closing the research-
clinical gap is the quality initiatives inherent to healthcare facilities and regulatory 
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organizations. The Joint Commission (JC), states' Department of Health Services (DHS), 
and the Institute for Healthcare Improvement (IHI) all communicate the need for a 
supporting quality program to monitor and improve patient outcomes. 
One conceptual framework that supports quality and research initiatives in 
healthcare organizations is the Quality Health Outcomes Model (QHOM), first described 
by Mitchell, Ferketich, and Jennings (1998). This model arose from a collaboration of 
researchers and policy-makers, under the auspices of the Agency for Health Care Policy 
and Research (now the AHRQ). An evolution of Donebedian's quality model, the QHOM 
broadened the understanding of nursing outcomes by illustrating the bi-directional 
influence that the patient and organization have on outcomes. There is no direct effect of 
interventions on outcome, but rather, all are impacted by the characteristics of each 
(Radwin & Fawcett, 2002). 
The QHOM supports the metaparadigm of nursing by incorporating the concepts 
of person, health, environment and nursing into the framework (Radwin & Fawcett, 
2002). This is ideally suited for nursing research, as the influence of nurses on patient 
care and outcomes is readily visible. The study design described here addresses all four 
paradigms as they relate to identifying NH residents with poor prognosis, so that 
discussions regarding goals of care can be initiated. 
Significance of the Study 
The significance of this study lays in the potential for healthcare providers to have 
available an accurate instrument that predicts mortality in NH residents. In the past, the 
clinical experience of physicians and nurses has provided direction for discussions 
regarding goals of care and recommendations for palliative treatment of people in the last 
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stages of advanced disease. An accurate prognostic instrument has the potential to be 
incorporated into decision-making as part of evaluating a person's clinical status 
holistically. For many patients and families, there is uncertainty regarding a shift to 
comfort care and away from curative or life-sustaining treatments. There is a great fear of 
abandoning a loved one, or stopping life-sustaining treatment when there is still hope of a 
reversal of clinical decline. Prognostication " . . . allows patients to make the most 
effective use of their emotional, fiscal and temporal resources and to regain a sense of 
control over lives thrown into disarray by serious illness" (Christakis, 1999a). 
Prognostication for treatment purposes is a medical responsibility, and not within 
the scope of practice of nursing practice. However, nurses routinely use predictive 
indexes to score patients for risk of an event (e.g. falls, pressure ulcers) and initiate 
activities to address these risks. Nurse ratings of a NH resident's mortality risk using a 
validated prognostic scale is therefore within the scope of nursing practice. The nature of 
this activity is data collection, assessment, and collaboration with physicians to 
communicate clinical condition, and to trigger discussions about goals of care, rather than 
to communicate prognosis to patients and families. 
Nurses receive no training in prognostication, or in the use of predictive models in 
basic academic curriculums. Yet, nurses spend more time with residents than any other 
discipline, and are able to contribute valuable insights to the interdisciplinary team (IDT). 
Use of validated prognostic tools to communicate risk does not in itself determine 
treatment. This author believes that there is minimal risk involved when trained nurses 
identify NH residents who meet criteria for palliative care or hospice referral, and 
communicate that information to the IDT. However, there are ethical and professional 
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considerations that provide some caveats to this perspective. These considerations will be 
discussed in greater detail in Chapter 5. Of the prognostic tools examined, the MDS-
CHESS has good utility and is simple to use. 
In future research, it may be shown that the MDS-CHESS scale can facilitate 
discussions regarding end of life care in this population. Indeed, the intent stated by 
virtually all investigators who have created prognostic models for NH residents is for the 
prognostic models to be used in this fashion. Having a prognostic tool that can predict 
mortality in NH residents and generate discussion of goals of care would provide 
valuable information with which a physician can offer realistic treatment options aimed at 
maintaining function, while minimizing suffering. The ultimate hope is that more 
residents will receive palliative and/or hospice support in the last six to twelve months of 
life, rather than aggressive interventions that will not improve that quality of life. 
Statement of the Problem 
The problem this study is designed to examine is that predicting death in NH 
residents can be difficult and complex, and delays in referral to appropriate supportive 
care results in undesired medical intervention and unnecessary suffering when clinical 
decline occurs. 
Purpose of the Study 
This study is undertaken to retrospectively determine survival of a cohort of NH 
residents and to determine whether the MDS-CHESS scale accurately predicts mortality 
within six months. Using an existing data set, relationships between mortality and scores 
on the MDS-CHESS scale will be evaluated. 
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Study Aims 
The focus of this study design is to replicate a previous research study in another 
patient population outside of the United States. With consideration of differences 
between healthcare systems, study elements were modified slightly during data collection 
and analysis to accommodate those differences. 
Aim #1: Determine the accuracy of the MDS-CHESS scale for predicting six-
month mortality in two American nursing homes. 
Aim #2: Determine whether there are differences in six-month post-admission 
mortality between two NH populations operated under identical regulatory and 
organizational rules. 
Implications for Nursing 
Nursing knowledge can be advanced by this study in several ways. Clinical 
nursing practice in NH is facilitated by use of evidence-based tools to evaluate risk and 
plan interventions. MDS nurses can screen for mortality risk during the admission 
assessment, without duplication of activities. Trained nurses with knowledge of the 
MDS-CHESS items could also score residents in the absence of a recent Resident 
Assessment Instrument (RAI) and obtain prognostic information. In daily clinical 
practice, this would be a valuable baseline to complete upon admission, and with any 
clinical changes. Since physicians are required to see NH residents only once a month, 
nursing use of this scale would assess relative risk and can prompt goals of care 
discussions on a more frequent basis. In this regard, nurses can have a direct effect on 
preventing unnecessary ED visits or hospitalizations by advocating for care appropriate 
to the resident's stated wishes. 
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Nursing education can be impacted on a variety of levels. Instruction of the NH 
nurses, supervisors and MDS coordinator on the value of accurate data entry and 
concurrent mortality risk assessment is likely to improve EOL quality indicators, and can 
decrease perceived liability as communication is enhanced. Supervisors have the 
responsibility and authority to mandate and monitor process changes that are expected to 
improve resident outcomes. Increased nurse comfort with the resident's transition to the 
active dying phase facilitates resident and family support and bereavement. Ancillary 
staff and other disciplines also benefit from this knowledge. Whenever additional eyes 
are trained on the NH resident, changes can be detected more readily, and modifications 
to the treatment plan are more likely. 
Nursing research on EOL care in NH has gained momentum in the last decade. 
Most studies concentrate on some aspect of hospice services or on the nursing staff 
providing EOL care. Additional studies are necessary to determine the effect of nurses on 
promoting good EOL outcomes. This study may have implications for nursing research 
as the basis for follow-up investigations of interventions and quality program 
modifications. Improving end-of-life care in the elderly is dependent on a number of 
complex factors including availability of fiscal and human resources, adequate 
organizational structure and effective care processes. Uncertainty regarding expected 
length of life and reluctance to address practical considerations often results in prolonged 
dying and avoidable suffering. The impact of sustaining life in the face of advanced 
disease is felt at all levels of care, and is just recently being evaluated more 
comprehensively from a population-based perspective. Much research remains to be done 
on identifying how and when to intervene for people with serious, chronic illness. 
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This investigation is informed by previous research and literature on administrative 
national databases, the MDS, clinical prognostication and the Quality Health Outcomes 
Model. Each of these topics will be explored to provide the framework for this study in 
the following chapter. 
Chapter Two 
REVIEW OF THE LITERATURE 
The purpose of this study is to determine the accuracy of the MDS-CHESS scale 
in estimating six-month prognosis in long-term care residents. Numerous studies and 
initiatives have suggested that the ability to predict mortality in people with advanced 
disease can minimize futile treatment, and refocus goals toward palliation at the end of 
life. Few predictions of mortality are absolute, and prognostic tools are best used to 
supplement clinicians' knowledge of patients' quality of life, and psychosocial and 
spiritual outlook. 
Improving end-of-life care in the elderly is dependent on a number of complex 
factors including availability of fiscal and human resources, and adequate organizational 
structure and effective care processes. Uncertainty regarding expected length of life and 
reluctance to address practical considerations often results in prolonged dying and 
avoidable suffering. The impact of sustaining life in the face of advanced disease is felt at 
all levels of care, and is just recently being evaluated more comprehensively from a 
population-based perspective. Much research remains to be done on identifying how and 
when to intervene for people with serious, chronic illness. This investigation is informed 
by previous research and literature on administrative national databases, the MDS, 
clinical prognostication and the Quality Health Outcomes Model. Each of these topics 
will be explored to provide the framework for the proposed study. 
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End-ofLife Research Using National Administrative Databases 
National administrative databases were originally created for billing and 
documentation purposes, and are only recently being explored for uses such as quality of 
care studies, population-based clinical outcome evaluation, and analysis of predictive 
measures. The use of databases for research must be considered in the context of whether 
the desired information is contained in the database, and how to link a sample with other 
databases to analyze endpoints or outcomes. One limitation of database studies is that the 
information submitted for inclusion may contain missing data, may be inaccurate, and is 
certainly dependent on the competency of person entering the data. Therefore, validation 
studies of national databases strengthen support for research use and ultimately, can 
guide interventions. Another barrier is the timeliness of access to electronic data from 
state or federal databases (Rantz & Connolly, 2004). Collated reports from the databases 
to the providers are usually not available for several months after data submission, 
limiting the opportunity to improve care for individuals and minimize adverse outcomes 
in a timely manner. 
Several investigators have utilized national databases to describe end-of-life care. 
Grunfield et al. (2006) described population-based indicators of quality of end-of-life 
care by linking the Canadian Vital Statistics database with cancer registries and other 
provincial databases. The investigators retrospectively measured 19 quality indicators and 
determined that seven indicators met the necessary criteria for inclusion in the study. 
Validation of the indicators was accomplished through concurrent chart abstraction of a 
random sample of study subjects (p. 773). This study added to the body of knowledge 
about quality of care at the end of life for breast cancer patients, and the usefulness of 
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retrospective design in a population that is difficult to research during the terminal stage 
of illness. 
Research measuring quality of life outcomes is seldom able to evaluate the 
contributions of nurses in promoting quality of life for seriously ill people. Doran, et al. 
(2006) analyzed nursing-sensitive outcomes in Ontario hospitals and long-term care 
facilities. One purpose of the study was to determine reliability of instruments measuring 
nursing-sensitive outcomes in hospital administrative databases and the MDS. The results 
revealed that, ". . . data collection by nurses on a broad set of outcomes . . . can be 
conducted reliably and validly" (p. S80). 
The investigators cautioned that data collection on nursing-sensitive outcomes 
should be considered carefully, and a plan should be created for establishing their utility 
in care planning and quality monitoring. This study had added significance because of the 
conceptual framework that informed its design. Using the Quality Health Outcomes 
Model and the Nursing Role Effectiveness Model, the investigators identified a broad set 
of outcomes that were already recorded during the normal course of patient care. 
Previous studies had identified an underrepresentation of nursing-sensitive outcomes in 
administrative databases. In summary, use of large national databases for health research 
has been shown to be an efficient and reliable method of evaluating and describing 
patient and population characteristics. 
Retrospective and prospective study designs both have merit in determining 
elements of good EOL care. Information from a sample of individuals can be applied to a 
similar clinical situation to provide guidance about an individual's present and future 
situation (Teno, 2005). By examining a cohort of individuals with common clinical 
16 
problems and diagnoses, studies can be designed to test hypotheses and answer questions 
with live participants, rather than through proxy or documentation in the medical record. 
Retrospective analyses eliminate the need for concurrent chart audit to identify those at 
risk of dying, as the time to event (death) has already occurred. This cost-effective 
method of conducting research also eliminates the patient burden of describing 
experiences and perceptions at a time of advanced illness near death. 
In discussing the methodological issues surrounding retrospective EOL studies, a 
noted expert in the field cited the need for "Mortality Follow-Back Surveys" (MFBS) to 
provide " . . . information on the dying experience including functional trajectory and the 
site of death, quality of life in the last year of life, and the use of hospice services" (Teno, 
2005). There have been six MFBS conducted in America thus far, the last done in 1993. 
These studies have provided data regarding access to healthcare and disparities between 
populations, and quality of life measures. Retrospective studies have provided compelling 
evidence that EOL care can be improved, and identified specific areas on which to 
concentrate research efforts. 
However, unresolved issues make retrospective database studies on EOL care 
problematic. First, there is no standard definition for the concepts of "terminally ill", 
"dying", "end-of-life", or "frailty" (Christakis, 1999a). Investigators do not always 
include a working definition of these terms in the study report. Therefore, minimizing 
risk of internal bias is more complicated. Triangulation of methods and using multiple 
sources of information has been recommended to understand EOL care more 
comprehensively (Teno, 2005). 
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Prospective studies are more difficult to conduct and should incorporate 
subjective data from patient or proxy in the research design. Few prospective studies have 
been conducted to date because of data collection difficulties. Patients are weary from 
prolonged illness and treatment, and may not be able to complete the necessary 
interviews or surveys. A proxy is beset by numerous functional and emotional 
responsibilities, and is providing responses that may not be an accurate reflection of the 
patient's experience. Identification of potential study participants is also problematic. 
Physician prognostication is a highly variable activity prior to the last stage of illness 
before death. Capturing patients and families in transition to an advanced stage of illness 
would yield information essential to knowing when to time discussions regarding a shift 
in priorities of care (Steinhauser, 2005). 
A central feature of prospective studies of people with serious illness is the focus 
on quality of life (QOL). Existing, validated QOL instruments measure constructs that are 
grounded in the present, rather than evaluating concerns about the future (Steinhauser, 
2005). This is not a realistic use of such instruments in the terminally ill population. 
Instead, quality of dying (QOD) instruments are necessary to capture the unique features 
of experiences prior to death (Steinhauser, p. S37). Improvements in prognostic accuracy 
can identify optimal timing of discussions about goals of care, and ultimately increase 
opportunities to measure quality of dying. This analysis does not have to be restricted to 
the last six months of life; it could begin with a baseline measurement at the time of 
diagnosis. Of particular concern is the length of time seriously ill patients spend in 
hospitals and care facilities as a result of aggressive treatment in the last stages of 
advanced illness. 
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The Dartmouth Atlas of Healthcare (2006) recently published a retrospective 
review describing the care of patients with severe chronic illness in the last two years of 
life. This was a comprehensive review of care at the end of life across the nation, as well 
as across the care spectrum. The focus of this report was to analyze care intensity and 
resource utilization in the Medicare population. National statistics were compared with 
state-specific data in 306 geographic regions across the United States. 
With mortality as an end point, investigators were able to evaluate resource 
utilization and quality of care at intervals in the two years prior to death. Figure 2.1 
delineates the number of hospital days per state in the last six months of life. It was 
revealing that people spent fewer hospital days in states that were less populous and 
therefore, had fewer hospitals and resources. 
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Figure 2.1 
Variation, by State, in Average Numbers of Hospital Days During the Last Six Months of 
Life (Center for Evaluative Studies, Dartmouth Medical School, 2006). 
Interestingly, the report determined that more intense care and utilization did not 
improve outcomes. In fact, regions with the highest intensity of utilization also had the 
highest mortality rates (Dartmouth Atlas, p. 16). Regions with the lowest resources and 
care intensity had less hospital days in the last months of life, possibly because facilities 
operated more efficiently or because there were fewer physicians available to admit 
patients. Another important measure of aggressiveness of care is the time spent in the 
Intensive Care Unit (ICU). A summary by state shows the number of days spent in the 
ICU in the last six months of life (Figure 2.2). 
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Figure 2.2 
Variation, by State, in Average Numbers of ICU Days During the Last Six Months of Life 
(Center for Evaluative Studies, Dartmouth Medical School, 2006). 
Fragmentation of care and lack of communication between healthcare 
professionals decreases the quality of care. With advancing illness and frequent 
hospitalizations, different physicians are providing therapeutic direction to patients. 
Commonly, no one physician is in charge of directing a person's care when advanced 
illness is present, creating confusion and increasing the chance of conflicting medical 
orders. 
The primary care physician who usually knows the patient best is often 
uninformed about treatment decisions made when patients are hospitalized. The amount 
of physicians involved in treatment decision-making in the last two years of life is well 
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demonstrated by this study. Figure 2.3 shows the percentage of patients who had more 
than ten physicians in the last six months of life. 
by State <0eathe -2000-03) 
Map 2.4. Variation, by Slate, in the Percent of • sofeorMov ,11, 
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Figure 2.3. 
Variation, by State, in the Percentage of Decedents Seeing Ten or More Physicians 
During the Last Six Months of Life (Center for Evaluative Studies, Dartmouth Medical 
School, 2006). 
In addition to the altruistic desire to improve care and decrease suffering at the 
EOL, there is an urgent need to approach resource utilization as a data-driven endeavor. 
Medicare spending for hospitalization and Part B ranged from $21,000 to $60,000 in the 
last two years of life, according to a study of calendar years 2000-2003 (Dartmouth Atlas, 
2006). Alarming increases have been noted in the intensity of care this decade 
(Dartmouth Atlas, p. 80). The demographic profile of hospitalized patients has not shifted 
radically in the last decade, with the majority of admissions continuing to be elderly 
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people (excepting obstetrical admissions). Therefore, more intense care is being delivered 
to the elderly, who traditionally have more co-morbidities and are frailer. Figure 2.4 
illustrates the rise in care intensity from 2000-2003. 
Rawm» •":-::,;.. •  2000 aqiM. awa :i&&---*imBmm-
:/}::^?:^,lw-ii^.: - : - - ' - . ' : : - . : -o : ; J ; 'K^ * * * » • ' 
Intensive caie beds 12.4 12.9 13.5 14.0 13.6% 
Medical specialists 7.& 61 6.5 8.9 13.4% 
Primary care physicians 6.4 8.£- 8.7 "3 0 7.7% 
Table 5.1, Increases In the Average Inputs of Intensive Care 
Bads, Medical Specialist Physicians, and Primary Care 
Physicians per 1,000 Chronically III Medicare Enrollees (2000-03) 
Figure 2.4 
Increases in the Average Inputs of Intensive Care Beds, Medical Specialist Physicians, 
and Primary Care Physicians per 1,000 Chronically III Medicare Enrollees (Center for 
Evaluative Studies, Dartmouth Medical School, 2006). 
The data from the Dartmouth atlas reveals the fiscal impact of failure to identify 
realistic goals of care in elders with chronic illness and provides a baseline from which 
improvements can be measured. 
The use of national databases will continue to provide valuable information 
regarding the care of populations, as well as identifying measures of care quality and 
benchmarks to aid in organizational decision-making. Further efforts should be expended 
understand and time interventions in prospective studies. A necessary evolution of 
research design is the conduct of studies that follow patients through the continuum. 
Optimal EOL care cannot occur in the vacuum of one care setting (e.g. acute care). 
Because people with serious chronic illness repeatedly cycle through all care settings, 
interrupting the cycle to reevaluate goals of care is a worthy effort. A person who is in the 
terminal trajectory of illness, responding to clinical crisis by providing adequate 
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supportive care can prevent unnecessary interventions that ultimately do not ease 
suffering, but prolong it. One logical point at which to interrupt the care cycle is in the 
nursing home (NH) setting, where the frailest patients are cared for. An examination of 
the NH database research on EOL care follows in the next section. 
The Minimum Data Set 
The Omnibus Reconciliation Act of 1987 mandated " . . . that Medicare and 
Medicaid-certified nursing facilities complete a comprehensive, accurate and 
standardized reproducible assessment. . ." for nursing home residents using the 
Minimum Data Set (MDS) (Carter, et al., 2006). The MDS is a survey of more than 550 
items used to assess Nursing Home (NH) residents upon admission, quarterly, and with 
significant changes in clinical condition. The first version of the MDS was implemented 
nationally in 1991; MDS version 2.0 was launched in 1995. A third version is currently 
under construction, and includes assessments related to palliative care. 
Originally developed for assessment and care planning purposes, the use of the 
MDS expanded rapidly to include provision of data for reimbursement, evaluation of 
quality indicators and health services research (Dellefield, 2007). The operations manual 
used by NHs to guide data collection contains Resident Utilization Guidelines (RUGs) 
and Resident Assessment Protocols (RAPs) to identify and organize information about 
common clinical problems, and provide direction regarding data collection and 
submission. Not exclusive to nursing care, this tool greatly facilitates interdisciplinary 
care planning. 
Original validation studies of the reliability of the MDS included multiple field 
trials and revision or deletion of some items (Morris et al., 1990; Hawes, Morris, Phillips, 
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Fries, & Mor, 1991). After several years of use nationally, questions emerged regarding 
the reliability of the data for research. Hawes et al. (1995) conducted small scale field 
trails and concluded that intraclass reliability was adequate for research purposes, 
provided the MDS RN Coordinators utilized the RAPs properly. 
Other investigators have validated different elements of MDS as quality indicators 
or to compare with existing clinical measurement instruments. Bates-Jensen et al. (2004) 
examined 15 nursing homes to determine the prevalence of bedfast residents and the 
effect on activity levels and mobility care. Results of this study surprisingly revealed that 
a higher prevalence of bedfast time did not equate with fewer activity interventions by 
nursing home staff. The significance of this study lies in the unexpected finding on a key 
quality indicator for NH. Traditionally it has been thought that more time in bed equates 
with less activity, and the reverse was found to be true. This study is valuable in 
addressing assumptions about NH processes and potential modifications to measure the 
bedfast quality indicators. 
Frederiksen, Tariot and De Jonghe (1996) conducted a cross-sectional 
correlational study of the criterion-related validity of the MDS with five existing rating 
scales. This study added to the validity of MDS data in assessing behavior, function, 
mood, communication, and cognition of NH residents. The correlation of functional 
scores with the Physical Signs and Symptoms Scale was high, as were the dementia 
scores with the Brief Psychiatric Rating Scale (BPRS) and the Mini-Mental Status Scale 
(MMSS). The MDS communication scores also correlated highly with the Mini-Mental 
Status Scale and the Psychogeriatric Dependency Rating Scale (PGDRS). Mood and 
behavior MDS items were less well correlated with the MMSS and the PGDRS scales. 
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The investigators attributed these negative correlations to the limited number of 
MDS items for mood and behavior. Standard ratings scales such as the MMSS, PGDSR 
and BPRS " . . . by design, encompass psychopathology more broadly in their 
description of psychiatric symptom characteristics" (Frederiksen, Tariot & De Jonghe, p. 
308). The authors acknowledge that the MDS is not intended to be a diagnostic tool, but 
has validity when compared to standard research rating scales. 
Burrows, Morris, Simon, Hirdes and Phillips (2000) advanced knowledge of 
MDS utility further with a study that identified MDS items that correlated with the 
Hamilton Depression Rating Scale (HDRS) and the Cornell Scale for Depression in 
Dementia (CSDD). The MDS Depression Rating Scale (MDSDRS) had high sensitivity 
with the HDRS and CSDD (95% and 78%, respectively) and minimal loss of specificity 
(72% and 77%, respectively). The implication for practice was to use the MDSDRS to 
screen for depression in residents, rather than completing an additional screening 
instrument. 
Fries, Simon, Morris, Flodstrom and Bookstein (2001) studied 95 NH residents to 
determine whether use of the Visual Analogue Scale (VAS) correlated with MDS pain 
items, and suggested that the MDS Pain Scale was easier to use. This is an important 
consideration with cognitively impaired residents who are not able to use the VAS to rate 
pain. Pain, depression and cognition influence chronic illness and the dying process, and 
the previous descriptions of validation studies of MDS as a research tool serve to support 
its use for researching prognostication of death. In summary, the MDS has been shown to 
be a versatile source of information on NH residents. 
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Prognosis and Prognostication 
Since the late 1800s, medical journals have provided a forum for discussion on 
the nature of disease and the patient's response to it. Underlying this discourse is the 
physician's role as the guide into the unknown realm of illness and uncertainty. As far 
back as 1934, physicians were lamenting prognosis as being difficult (Christakis, 1999a). 
In Death Foretold: Prophecy and Prognosis, an ethical code regarding prognosis 
becomes apparent in the following quote: 
"The ability of physicians to prognosticate is equated with showing restraint, 
maintaining a sense of perspective, and knowing one's own limits. Acting on predictions 
to avoid such disrespectful overtreatment required assiduous data collection, substantial 
learning, excellent judgment, and considerable courage. It also requires a commitment 
not to abandon the patient" (p. xiv). 
Physicians' estimates of prognosis vary widely, depending on the physician 
specialty and familiarity with the patient. This results in a prolonged dying process 
brought about by extended medical treatment that will not produce a long-lasting 
solution. When there is little treatment available for a particular illness, prognosis by the 
physician is a prominent influence on treatment decision-making. When there are 
available treatments, " . . . physicians will blithely neglect prognosis" (Christakis, p. xix). 
The ability to sustain life when catastrophic cardiac or pulmonary failure occurs 
was greatly increased with the advent of cardiopulmonary resuscitation (CPR) in the 
1960s. Since that time, advances in therapeutic interventions and diagnostic technology 
have prevented death and organ failure in countless people. Intensive care units (ICUs) 
and emergency departments (ED) have improved the care of critically ill people through 
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coordinated efforts of medical specialists (e.g. trauma, cardiology), the Emergency 
Medical System (EMS) network, and hospital support systems. These advances have also 
created significant ethical dilemmas because the dialogue surrounding death and dying 
has not matured along with technological capabilities into effective communication 
between patients, families and healthcare professionals. To ameliorate this gap, national 
experts, research entities and the government have collaborated to produce guiding 
documents that disseminate research and make recommendations for policy and 
regulatory changes (IOM, 1997; 2003). 
Improved management of progressive, chronic illness has prolonged life and 
allowed Americans to retain productivity and quality of life through various stages of 
disease and disability. These advances have also resulted in a prolonged dying process 
that has impact beyond the personal suffering that occurs. The financial and emotional 
toll of disease remissions and exacerbations is felt by loved ones as they respond to the 
changes brought about by increased dependency. Patients fear losing control and 
suffering needlessly (Connors, et al., 1995). The cultural shift in our society that brought 
about the Right-to-Die movement has produced encouraging progress. Healthcare 
professionals are engaging with ethicists and consumers to discuss when to prolong life, 
and the relative benefits of life-sustaining treatments. A significant barrier that creates 
uncertainty in this discussion is the difficulty in determining prognosis. 
As a result, there has been an increased emphasis on discovering methods and 
support tools that will aid in reliable prognostication. Many clinicians rely on biophysical 
data as well as intuitive insights to communicate recommendations and timing of 
treatments. Often, these discussions occur during crisis, or do not happen at all. Studies of 
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physicians reveal that they pursue treatment for patients that they would not choose for 
themselves or their loved ones (Connors, et al., 1995). Other research has provided 
conflicting information regarding whether physicians' prognosis is overly optimistic or 
pessimistic (Connors, et al., p. 1592). In general, it has not been observed that prognostic 
models are widely used in the hospital setting to aid in treatment determination, with a 
few exceptions (e.g. burn and intensive care patients). It is postulated that this is because 
physicians receive very little training in using prognostic systems in medical school and 
residency, and nurses are unlikely to receive any training on prognostication in their 
entire career (Christakis, 1999a). 
Prognostic Models 
Several systematic reviews of prognostic models, tools, or other predictive 
measures have contributed to understanding the scope of research that has been 
completed in the past. This organized approach is done within several contexts; that of 
palliative care and terminal cancer. Vigano and colleagues (2000) reviewed major 
literature databases until 1999 and found that there were five independent predictors of 
survival in the terminal cancer population: performance status, presence of cognitive 
failure, weight loss, dysphasia, anorexia, and dyspnea. Physicians' estimations of patient 
survival only showed an association of small magnitude. This review added valuable 
information by identifying specific criteria to describe the terminal phase of cancer, and 
substantiating support for the Terminal Cancer Syndrome Theory, previously described 
in related literature, but not supported by research. These predictors crossed many types 
of cancer, and helped to explain the subpopulation of cancer patients who die despite 
only a moderate stage of cancer. 
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Other investigators evaluated survival studies through the palliative care 
perspective. Coventry, Grande, Richards, and Todd (2005) reviewed studies of prognosis 
in hospitalized and community-dwelling elders. Because the prognostic models that exist 
have poor discrimination in non-cancer patients, it was necessary to identify independent 
predictors in non-cancer populations that generally are thought to have poor prognoses. 
Six independent predictors were identified: 
• Increased dependence in activities of daily living; 
• Presence of co-morbidities; 
• Poor nutritional status; 
• Weight loss; 
• Abnormal vital signs; 
• Abnormal lab values. 
These data are easily obtainable from the patient's medical record, and can serve 
to make available palliative or hospice services to maintain comfort of a physical, 
psychosocial and spiritual nature. However, the authors note, ".. . uncertainty about the 
onset of palliation and time to death in older, non-cancer patients is, undoubtedly, 
compounded by problems of prognostication in this group" (Coventry, et al., p. 226). 
They suggest that a mixed model of active and palliative treatment may serve this 
population better than one or the other. The unpredictable nature of non-malignant, 
terminal disease makes delivery of quality EOL care difficult. Identification of 
independent predictors can be of great use to clinicians involved in the care of such 
patients. 
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Although survival time is one of the first concerns expressed by patients receiving 
a life-threatening diagnosis, clinicians often provide inaccurate estimates of prognosis. 
One would think that the availability of supportive tools would enhance prognostic 
estimates. It is clear that there is no famine of evidence-based prognostic instruments. In 
a recently published systematic review of prognostic tools for palliative care, over 20 
examples were identified from the literature (Lau, Downing, Lesperance, Shaw, and 
Kuziemsky, 2007). The tools were disease-specific, or non-disease specific. Limitations 
of the reviewed tools, such as the need for further validation in different populations, and 
lack of consistent reporting of prognosis and its interpretation, will be further discussed. 
One problem with prognostic systems is that they were created from a patient 
sample at one point in time, and then tested for internal reliability. It was not known 
whether a prognostic system was generalizable to future patient samples. In an article 
about assessing generalizability, one study from 1987 was cited that addressed the 
problem of the degradation of such systems in subsequent patient populations and created 
some baseline criteria forjudging longitudinal rigor (Justice, Covinsky, & Berlin, 1999). 
Justice and colleagues (1999) outlined essential factors for consideration of the 
utility of a prognostic system. Accuracy is determined by measures of calibration and 
discrimination. Calibration is demonstrated by plotting of predicted and observed 
outcomes. Discrimination is measured by the Receiver-Operating Characteristic (ROC) 
curve. Generalizability is evaluated by reproducibility and transportability. Resampling 
methods can determine reproducibility in a sample similar to the sample in the original 
study. Transportability is analyzed depending on the intended application to the system, 
and is tested in a sample that is non-identical or homogenous to the original study sample. 
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The preceding concepts are significant considerations in the current quest for 
evidence-based healthcare and outcome measurement. Treatment recommendations for 
serious illnesses arise from staging and prognostic systems that may have degraded over 
time or were not ever formally tested for external validity. It is possible that the same 
perspective holds true for prognostic systems that inform goals of care. Testing the 
external validity of the MDS-CHESS scale will add to the body of knowledge regarding 
estimating prognosis in NH residents. 
The following section will provide an overview of prognostic models and tools as 
they relate to prediction of mortality and desired influence on determination of goals of 
care. Disease-based prognostic methods will be discussed, as well as models used in 
acute and long-term care to enhance understanding of this complex, imprecise process. A 
discussion of the value of prognostication in advanced disease will complete this section. 
Disease-Based Prognostication 
It is important to distinguish between disease-based prognosis for treatment 
purposes, and prognosis determination to inform goals of care. When delivering a new 
diagnosis to a patient, a physician must be prepared to interpret the meaning of an 
individual's clinical information in the context of a global understanding of that disease, 
its natural history, and expected responses to current treatment. Disease-based prognostic 
systems have been created to ".. . generate predictions for patients whose outcome is not 
yet known" (Justice, et al., 1999). 
One of the most comprehensive and mature uses of disease-based prognosis exists 
within the field of oncology. Development and refinement of staging systems by the 
American Joint Commission on Cancer (AJCC) has provided clinicians with a template 
for evaluating degree of disease and a baseline for treatment (AJCC, 2008). Diagnostic 
testing can accurately pinpoint the primary source of tumors and most metastatic sites. 
Extensive research studies on multimodal cancer treatments have identified which stage 
of disease is most likely to respond to a given treatment plan. Much attention is given to 
survival percentages (as determined by the Kaplan-Meier curve) that are based on one 
stage of a specific type of cancer and its response to a treatment approach. As cancer 
treatments have improved and patients survive longer, equally important is the attention 
given to managing the sequelae of disease and treatment. From this origination point, 
researchers began investigating prognostic systems for advanced illnesses to facilitate 
appropriate care, improve communication with patients and families, and minimize 
suffering during the last stages of life. 
Within the literature on specific diseases there are prognostic indicators designed 
to evaluate time to event, such as death. In the terminal cancer population, estimates of 
time remaining prior to death can be inaccurate, potentially leading to continuation of 
therapy, or less aggressive comfort measures. One such prognostic indicator is the 
measurement of uric acid levels in the last weeks of life. It has been shown that uric acid 
levels greatly increase between the first and second weeks prior to death (Shin et al., 
2006). This information can be quite useful in predicting time of death with some 
accuracy. Families wish to know with as much certainty as possible, how long a loved 
one may linger before dying. This is an indication of achieving some measure of control 
over a difficult process, in addition to more practical considerations such as funeral 
planning and gathering of family. 
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Other investigators have stratified terminal cancer patients into homogenous risk 
categories in order to minimize over- or undertreatment, and to stage the terminal phases 
of cancer for estimation of survival. Pirivano et al. (1999) created the Palliative 
Prognostic Score (PaP) which resulted in three risk categories for survival. Statistical 
significance was determined for survival in Group A (64 days), Group B (32 days), and 
Group C (11 days), based on simple clinical measures. These risk categories were 
thought to have utility in clinical practice for treatment and to support decision-making. 
A similar prognostic index for palliative cancer patients was developed by Morita 
and colleagues (1999), with some overlapping variables. Efforts to develop the Palliative 
Prognostic Index (PPI) in Japan progressed almost simultaneously with the Pirovano 
group work in Italy. This study sought to group patients into survival risk categories and 
successfully demonstrated that distinct patient profiles, or "bands" emerged from the 
data. By contrast, subsequent researchers found conflicting results in replication studies. 
A British Columbia research group found distinct survival curves but no profiles or 
"banding" (Lau et al., 2006), while Australian researchers confirmed broad applicability 
in a different setting (Glare & Virik, 2001). This can be interpreted to mean that although 
the PPI had validity for survival prognosis, it is unclear whether the generalizability 
across different samples is consistent. This is an important point to resolve in future 
studies. Categorization of terminally ill patients into groups with distinctly different 
survival curves can allow clinicians to tailor therapeutic and care needs in congruence 
with the expected prognosis of each group (Glare & Virik, p. 894). 
This type of prognostication for treatment purposes has advanced the knowledge 
of response to cancer therapy, and shifted the diagnosis from a terminal disease to one 
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that is more chronic, albeit life-limiting. Similar methods of staging and prognostication 
are utilized in the cardiology, rheumatology, pulmonology and infectious disease 
specialties. The progression of chronic, life-limiting diseases may be slowed or put into 
remission by medical therapies and lifestyle modification. In this way, prognosis can be 
modified and quality of life improved. As a disease advances over time and the effects of 
aging influence response to treatment, it becomes prudent for the healthcare provider to 
determine with the patient which medical measures continue to be meaningful. 
It is not the focus of this study to examine disease-based prognosis. However, it 
is necessary to consider the underlying principles of prognostication in chronic disease 
management in order to understand the trajectory of an illness, perceptions of quality of 
life, and what informs people in making decisions regarding goals of care. Disease-based 
prognostic models have been primarily used during the diagnostic phase of treatment. 
During a healthcare crisis, it becomes necessary to evaluate prognosis from a mortality 
perspective, rather than a response-to-treatment perspective. The next section will 
examine the literature on prognostication in the acute care setting, which in turn 
influenced subsequent studies in long-term care. 
Acute Care Prognostic Models 
One of the first attempts to classify critically ill patients was the creation of the 
Acute Physiology and Chronic Health Evaluation (APACHE) prognostic model. This 
model predicts risk of death by measuring severity of illness in the ICU population and 
assigning a score. From information readily available in the medical record, investigators 
compared mortality and outcomes of ICU patients to physiologic measures for each day 
in the ICU. Validity was confirmed, as well as sensitivity to all measures (Knaus, Draper, 
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Wagner, & Zimmerman, 1985). In a validation study of a revised version of the 
APACHE, Knaus, et al. (1991) found that a five-point increase of the patient's APACHE 
score was associated with a significant increase in hospital death. Overall, risk estimates 
were within 3% of actual mortality in this study. This has proven to be a valuable tool for 
estimation of risk of death when completed on the first day of ICU admission. Figure 2.5 
below illustrates the survival curve for a sample population of patients with subdural 
hematomas, sepsis, pneumonia, and gastrointestinal perforation. 
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Figure 2.5 
Relationship Between APACHE III Score and Predicted Risk of Hospital Death (Knaus, 
W.,etal.,1991). 
Other authors have studied the APACHE model to determine utility in patient 
populations such as abdominal sepsis (Bohnen, Mustard, Oxholm, & Shouten, 1998); 
Multiple Organ Failure Syndrome (Cerra, Negro, & Abrams, 1999); resource utilization 
and mortality in Coronary Artery Bypass Graft (CABG) patients (Becker et al., 1995); 
and renal failure (Maher et al. 1989). In conjunction with physicians' predictions, the 
APACHE model has proven useful in prognosis of critically ill patients, although it is not 
used in all hospitals. 
Even in the presence of available prognostic models, it was clear that patterns of 
treatment were not changing. It was theorized that creation of support mechanisms in 
addition to prognostic systems would influence the delivery of inappropriate care to 
patients who were expected to die within a short time frame. The Study to Understand 
Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT) trial was 
a pivotal study of five academic medical facilities that sought to examine outcomes and 
clinical decision-making in ICU and non-ICU patients (Knaus et al., 1995). One aim of 
the study was to determine if prognostication could be improved upon, beyond existing 
tools and clinician experience. Unique to other studies on prognosis, patients were 
followed for 180 days after hospitalization and were not severely physiologically 
imbalanced or critically ill (Knaus et al., 1995). This study was conducted in two phases, 
and observed the process of decision-making and patient outcomes. The first phase 
consisted of the development of a prognostic model and phase two compared the 
SUPPORT model to an existing prognostic model and to individual physician's 
prognoses for their patients. 
The phase one SUPPORT prognostic score was based on the disease category, 
degree of physiologic abnormality, estimates of the patient's long-term health, and the 
number of hospital days before entry into the study (Knaus, et al., 1995). The SUPPORT 
prognostic score was calculated on day three of the study, and proved to be the important 
predictor of survival. The Glasgow Coma Scale score was the most significant predictor 
of death. Most patients want to know their prognosis and current thought supports use of 
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prognostic estimates due to " . . . evolving professional and societal consensus...that 
prognostic data should be shared in the context of the patient-physician relationship, 
which is based on trust" (Knaus et al., p. 196). The investigators concluded that the 
SUPPORT prognostic score should be used in conjunction with the physician's estimate 
of an individual's mortality risk. This was an important step forward in creating tools for 
clinicians to guide patients and families in decision-making. 
Phase two of the SUPPORT study utilized an intervention to conduct a cluster 
randomized controlled trial based on the prognostic model developed in phase one. Study 
nurses reviewed hospital admissions and ICU patients daily to determine eligibility of 
patients, and facilitated discussions and patient care conferences. Discussions included 
appropriate diagnostic and prognostic information, and determination of patient and 
family understanding of disease prognosis and treatment. Study outcomes were 1) timing 
of written Do Not Resuscitate (DNR) orders; 2) patient or proxy discussions with the 
physician occurring in the first interview on preferences for withholding resuscitation; 3) 
days spent in the ICU; 4) pain analyses; and 5) resource utilization. These outcomes were 
chosen as they represented common EOL quality of care indicators. 
Four of the five outcome measures showed no difference between the 
experimental and control groups. Pain analysis was the only outcome that showed a 
difference, with the intervention group having slightly higher reports of pain than the 
control group. This could be explained by the increased awareness of pain as a priority of 
care in the intervention group. Unfortunately, half of the conscious patients in the study 
reported moderate or severe pain in the last days of life. All other interventions were not 
statistically significant for improvement. The findings were surprising; as it was 
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commonly thought that more focused resources on complex EOL decision-making would 
improve outcomes. This was not the case. It is disappointing that prior recommendations 
from EOL experts for improved processes and communication failed to produce the 
desired outcomes. However, patients, families and physicians reported high satisfaction 
scores with the personnel and processes that supported care. One of the strengths of the 
SUPPORT study was demonstration of a study design that reflected the many elements 
involved in care of the seriously chronically ill patient. 
Soon after the initial SUPPORT studies were published, researchers at Stanford 
University Hospital in San Francisco shifted the perspective from predicting mortality 
calculated from scores of abnormal physiology (as determined by the APACHE III 
model) to estimates of ICU care that is potentially ineffective (Esserman, Belkora, 
Jeffery, & Lenert, 1995). They reasoned that mortality was not necessarily an indicator of 
ineffective care. Retrospectively analyzing APACHE III scores from day one and day 
five in the ICU, the investigators constructed a model predictive of Potentially Ineffective 
Care (PIC). Threshold levels were calculated from the APACHE III scores that were 
sensitive and specific enough to categorize subjects into PIC or non-PIC groups. Early 
identification of PIC patients was necessary to shift clinical efforts to a supportive focus. 
If patients had not responded to treatment by day five, then they were grouped into the 
PIC category. 
Effectiveness of the model also depends on resource utilization savings. The 
investigators applied a supportive care guideline to the database sample after 
determination of PIC was made. This allowed interventions of high care intensity to be 
limited and cost savings projected. 12.9% of the ICU patients in the sample used 32% of 
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the resources. Implementation of a supportive care guideline in PIC patients was 
projected to save $1.7 million over the six-month study period. As compelling as the 
results of the PIC study were, it was clear that physician behavior change needed to 
accompany use of the model in order to realize resource savings and the shift to 
supportive care for PIC patients. 
One of the strengths of the SUPPORT study was that it followed patients beyond 
a short-term time frame, and analyzed mortality at 180 days. This was significant, as 
prior studies concentrated on survival until discharge from the intensive care setting or 
from the hospital. It was suspected that long-term survival was not realized despite 
aggressive measures during hospitalization, which was validated by the SUPPORT study. 
Another surprising finding was that age was not a significant factor in survival, which 
was contrary to popular thought. 
The SUPPORT study generated a number of other research studies based on the 
same sample of participants. Hamel and colleagues (1999) examined the effect of age on 
short-term survival, independent of aggressiveness of care and patient characteristics. It 
was demonstrated in this sample that elderly people receive less aggressive treatment 
than younger patients with the same diagnoses. This was not, however, due to less 
intensive care care. Contrary to popular thought, age had only a small effect toward 
increasing short-term mortality; more influential were diagnosis and severity of illness. 
The investigators concluded that age was not an independent factor in short-term 
mortality. 
In a follow-up to the previous study, Teno and colleagues investigated 
hospitalized elders (80 years and older) to develop a predictive model that estimated 
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mortality at ten months post-hospital admission (Teno et al., 2000). The investigators 
coordinating the Hospitalized Elderly Longitudinal Project (HELP) were able to predict 
survival by analysis of routine hospital admission data. In addition to hospital-generated 
database information, the study elicited patients' and families' preferences for life-
extending or life-foregoing treatment in the future. Physicians were asked a similar 
question about patient preferences, in addition to offering an opinion about whether they 
thought the patient would survive for two months following enrollment. The authors cited 
previous research confirming that congruent patient and physician preferences for 
treatment resulted in shorter life spans. In this study, only the physician's perception of 
patient preference predicted survival time. This area of interest requires further research 
to explain any correlation between mortality and physician's perceptions of patient 
preferences for life-extending treatment. This added to the body of knowledge of survival 
prediction by identifying a potential confounding variable (the physician's perceptions), 
and by demonstrating that age has only a modest relationship to mortality in the seriously 
ill. These findings are relevant to the proposed study, as nurses collect prognostic data 
during the course of normal assessment processes in NH. Therefore nurses have access to 
information that informs prognosis, and can facilitate goals of care discussions upon 
screening evaluation of mortality risk. 
The final study to be discussed related to acute care is the Veterans 
Administration study by Walter et al. (2001) that examined one-year mortality in older 
patients after hospitalization. Using data accessible at time of discharge, investigators 
identified risk factors that were hypothesized to be associated with one-year mortality and 
measured each risk factor against mortality in a derivation and a validation cohort (from a 
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local community hospital). The final set of six risk factors was developed into a bedside 
tool with a simple point-scoring system. Upon completion of the tool, points were totaled 
and the score evaluated for placement in each of the quartile risk designations. The 
prognostic index demonstrated validity and stratified patients into risk categories. The 
model was shown to have good calibration and discrimination, as well as generalizability. 
This tool can be useful across care settings, provided access to data at discharge is 
available. For those patients who are discharged to NH, this information can guide 
discussions regarding treatment decisions and subsequent hospitalizations, or serve as 
additional validation of future assessments and alterations in the treatment plan." 
Prognostic Models in Nursing Homes 
The development of prognostic models in NH has followed a similar path as that 
of the acute care models. In numerous studies, retrospective samples from the MDS have 
been cross-referenced to state and national databases or the Medicare database to validate 
survival within a certain time frame, or to stratify risk of death (Abicht-Swensen & 
Debner, 1999; Hirdes, Frijters & Teare, 2003; Mehr et al., 2001; Mitchell et al., 2004; 
Porock, et al., 2003; and van Dijk et al., 1999). Residents of NH usually have 
comorbidities, poor functional status, and are frail but stable. Detecting subtle instabilities 
of health can be challenging in any patient population. NH caregivers are familiar with 
variations in mood and communication of the residents, and therefore, may not detect 
changes until they are more pronounced, and require more intense care. Instabilities of 
health can be thought of as a consequence of frailty, which makes a person more 
vulnerable to stressors of a medical, environmental or psychosocial nature (Hirdes, 
Frijters, & Teare, 2003). Given the common scenario of catastrophic decline or failure to 
42 
rehabilitate after an adverse event (e.g. falls, pneumonia) in NH residents, it is logical to 
proactively evaluate risk of death in a fashion that is efficient and accurate. The following 
descriptions of prognostication research in NH residents demonstrate that there are 
overlapping variables, and several methods of accomplishing this outcome. 
Most retrospective survival studies in NH residents focus on specific diseases and 
have an end-point set at the six-month mark. That is, survival is calculated six months 
from the date of the first MDS assessment. This time frame coincides with the criteria for 
hospice admission, which requires that patients receiving the hospice benefit are thought 
to have six months or less to live. It is hoped that identification of reliable prognostic 
indicators can support the decision to forego aggressive care in people who do not have 
long to live, and facilitate hospice admission. 
An international group of investigators examined the correlation between 
mortality and multiple comorbidities in NH residents (van Dijk et al., 2000). Because 
functional status, disease, gender and age are common influences on mortality, van Dijk 
and colleagues used regression analysis to determine which comorbidities had a 
synergistic effect on mortality. The sample was followed out to one year to determine 
survival. Contrary to expectations, no disease combinations demonstrated synergistic 
effects, after controlling for age, gender, and functional status. Not unexpectedly, cancer, 
heart failure, renal failure, Chronic Obstructive Pulmonary Disease (COPD) and diabetes 
were strongly related to one-year mortality. 
This study is unique in design among other NH survival models, as it utilized 
regression analysis rather than the Cox Proportional Hazards analysis. However, the 
authors stated that the results were not essentially different from the proportional hazards 
model. The value that this study added in the evolution of prognostic models for NH 
residents was that there was no demonstrable merit to comorbidities in a survival 
analysis. Subsequent investigators have included diseases into their models, but not the 
presence of multiple diseases in the scoring systems. 
Other researchers have focused on using the MDS to estimate short-term 
mortality of NH residents in specific situations. Abicht-Swensen and Debner (1999) 
analyzed NH residents on hospice to determine indicators of short-term mortality. They 
found that a decrease in functional status resulted in death within 15 days for 74% of the 
sample. Functional status decrease was defined as a significant decline in 
communication, ADLs, incontinence and nutrition. These were strong predictors 
regardless of age, gender and diagnosis. Although this information can be valuable to 
staff and families, it does not add significant knowledge to the body of work on 
estimating prognosis to reassess goals of care. 
Several years later, Mehr and colleagues (2001) examined NH residents with 
Lower Respiratory Infections (LRI), a common cause of mortality and functional status 
decline. The purpose of the study was to determine 30-day survival in residents with the 
diagnosis of LRI. A point-scoring system allowed the investigators to stratify the sample 
into risk categories. More than half of the sample had a relatively low risk of mortality. 
The value of these results lies in the ability to identify NH residents with a higher risk, in 
order to approach the treatment plan in a manner that improves chances of survival or a 
shift to comfort care. 
Another diagnosis with a perplexing prognosis is that of dementia. In recent years, 
hospices have expanded their scope of admission diagnoses to include advanced 
dementia. Many people with dementia enter NH because of behavioral and safety 
problems, rather than a serious decline in functional status. Yet, this patient population 
has a great need for symptom management and comfort, and individuals are not able to 
communicate their needs. Families experience great distress as well, and need support as 
their loved one becomes less and less accessible. Thus, patients are appropriate for 
hospice support. More recently, hospices have been challenged by regulatory bodies to 
demonstrate that advanced dementia patients have a six-month prognosis (L. H. Sumner, 
personal communication, January 18, 2007). 
Studies that have evaluated dementia and it correlation to mortality have shown 
that it is not an independent predictor of survival (Glare, Eychmueller, & Virik, 2003; 
Hamel et al., 1999; Lau et al. 2006; and Van Dijk et al., 2000). Even in residents with 
advanced dementia, time to death has been difficult to estimate. Use of the Functional 
Assessment Staging (FAST) scale has been the standard of care for dementia assessment, 
and has been incorporated into several prognostic models. A subset of the MDS, the 
Cognitive Performance Scale (CPS) has also been used in this manner. Neither tool was 
created for, or is primarily used to estimate survival but rather, is intended to stage 
dementia. 
A multi-state, longitudinal study sought to create a prognostic model to evaluate 
NH residents with advanced dementia for survival. Resident data from the MDS for New 
York and Michigan NH were analyzed to stratify risk, using a derivation and a validation 
cohort (Mitchell et al., 2004). Results from both cohorts were statistically similar, and the 
Area Under the Receiver Operating Characteristic (AUROC) scores were 0.74 and 0.70 
for the derivation and validation samples, results which indicate good specificity and 
sensitivity. AUROC scores are utilized to demonstrate probability of an event, and have 
been used in healthcare for many years to aid in decision-making (Wikipedia, 2007). The 
risk score from this MDS-derived index was shown to be superior to the FAST scale for 
predicting mortality in residents with dementia. 
The preceding studies were based on data derived from the MDS and addressed 
disease-specific conditions, or were created to estimate mortality when NH residents 
were already known to be dying. As prognostic models have evolved over the last 
decade, more sophisticated methods have been employed to refine and strengthen the 
studies. Of interest is that the MDS is used outside of the United States with populations 
similar to American NH. Validation of prognostic models elsewhere increases the 
generalizability of such models, and provides more decision-making tools to clinicians. 
Some of these studies have provided baseline data for NH residents regarding survival in 
certain circumstances, but are sophisticated in design, and may require data retrieval from 
several sources. Some models require a learning curve to implement in the organizational 
support structure because they must be built into the routine of care and documentation. 
Most of the models assert that they are simple tools to use, and rely on readily retrievable 
data. Two recent studies demonstrate a simple scoring system that supports the claim of 
utility (Hirdes, Firjters, & Teare, 2003; and Porock et al., 2005), and truly rely on readily 
available data from MDS items. 
In 2005, researchers in Missouri further refined the analysis of mortality using the 
MDS, and corrected for limitations noted by investigators in prior studies (Porock et al., 
2005). Using a retrospective design, MDS items with a potential to correlate with dying 
or poor prognosis were isolated into the categories of demographics, diseases, clinical 
signs and symptoms, and adverse events (Porock, et al., p. 492). Cognitive performance 
and functional status were represented by MDS items known from previous research to 
be reliable indicators for these constructs. 
The sample consisted of all Missouri NH residents over 65 years of age who were 
admitted to NH in 1999. Files that were missing last name, sex, or Social Security 
Numbers (SSN) were excluded from the data set. Seventy-five percent of the sample 
became the developmental or derivation cohort, and twenty-five percent was designated 
for the validation cohort. This allowed testing of the model testing from a similar sample. 
Fourteen variables were determined to comprise the MDS Mortality Risk Index (MMRI), 
whose items were calculated through stepwise regression. Discrimination and calibration 
were demonstrated by distribution of the Kaplan-Meier survival graph and a satisfactory 
match of expected and observed deaths in each decile, respectively (Porock et al., p. 494). 
One limitation of this study was the lack of ethnic diversity. The study proposed by this 
author addresses that limitation by developing the study sample from an ethnically 
diverse NH population in southern California. 
Prior to the Porock et al. study (2005), Hirdes, Frijters & Teare (2003) conducted 
a retrospective analysis of residents of a Complex Continuing Care (CCC) hospital in 
Toronto, Canada. CCC hospitals are similar to American NH, but house patients with far 
more complex medical conditions, including neurological and degenerative disorders. 
Residents typically stay for years, post-hospitalization, or are admitted from the 
community due to clinical deterioration (Hirano, 2003). The Canadian Institute for 
Healthcare Improvement has required CCCs to utilize an assessment system similar to the 
MDS requirement from OBRA '87 for American NH. As a result, Canadian long-term 
care facilities utilize the MDS for assessment and quality trending purposes (CIHI, 2004). 
In this retrospective study, investigators sought to explore whether subtle 
instabilities of health could be detected prior to imminent catastrophic decline. Instability 
of health was thought to be a component of frailty, which is difficult to observe, but is a 
common description of institutionalized patients. The study was designed to determine 
whether health instabilities were correlated with survival. 
Using the MDS database, a sample was created from residents admitted to CCCs 
from July, 1996, to May, 1999. MDS items that were thought to be indicators of changing 
health status were derived from three sections of the MDS - Changing Health, End-stage 
Disease, and Symptoms and Signs of Medical Problems (Hirdes, Frijters & Teare, 2003). 
This was a novel approach to estimating prognosis, as most other prognostic models 
incorporate functional and cognitive status as key indicators. The MDS-CHESS scale 
does not do so. 
The proportional hazards model was used to examine the relationships between 
the items constituting the MDS-CHESS scale and mortality. Items were required to 
achieve a hazard ratio of at least 1.5, and a p-value of less than 0.05 for inclusion in the 
scale. Six score levels were identified from stratification, ranging from 0 (no instability) 
to 5 (highest level of instability) (Hirdes, Firjters, & Teare, p. 98). Associations with 
functional and cognitive status, as well as depression, were weak, indicating a distinctly 
different domain was being measured in the MDS-CHESS scale. 
The MDS-CHESS scale was determined to be a brief, simple scoring system that 
has use in daily practice to detect health instabilities. MDS assessments are done upon 
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admission to long-term care, quarterly, and with a significant change in health status. 
Therefore, there may be changes that go undetected for some time before another 
assessment is done, and data can be retrieved for scoring in a prognostic index. The 
MDS-CHESS scale contains nine items, all of which can easily be determined by a brief 
chart review, or in conversation with NH caregivers. 
The investigators of this study recommended that it be replicated in a typical 
long-term care facility containing a more stable, chronically ill population than the 
higher-intensity residents of the CCCs. A limitation of this study was that there was no 
mechanism to determine if residents discharged from the CCCs had died within the six-
month time frame. Therefore, there is missing data of an undeterminate volume, as the 
authors did not include the actual percentage of residents for whom survival could not be 
confirmed after discharge. The investigators were unable to cross-reference missing 
resident data with a vital statistics database for unstated reasons. Therefore, a replication 
design would have to include cross-referencing with a governmental database that 
includes mortality statistics. 
This study seeks to replicate the Canadian study by Hirdes and colleagues (2003), 
rather than the Porock et al. study of 2005. Testing of the MDS-CHESS scale rather than 
the MMRI has several practical rationales. First, the settings from which the sample will 
be derived is more ethnically diverse and medically stable than that of the Canadian CCC 
hospital, but are hospital-based and have post-acute short-term rehabilitation patients. 
This approach follows a research recommendation of the Canadian investigators. 
Secondly, the items on the MDS-CHESS scale reflect instability of health, which can 
alert NH practitioners to conditions that are potentially reversible, or to those conditions 
for which interventions can improve comfort in those residents who are not actively 
dying. The MDS-CHESS scale items are also fewer in number than those on the MMRI. 
The items that comprise the MDS-CHESS scale are predictive and 
independent of age, gender, and disease. With the MMRI and other prognostic 
scales, common diseases like cancer and heart failure are built into the scoring systems. 
American NH routinely provide interventions such as intravenous fluids, and the 
sample settings have attentive physician presence routinely (both are MDS-CHESS 
items). It is reasonable to expect that physician change orders and visits will accurately 
reflect clinical decline. Many NH do not have the level of physician presence because 
they are not hospital-based as the sample NH are in the proposed study. This could be a 
confounding variable if samples were derived from hospital-based and non-hospital-
based settings. Broader sampling may be included in the design of a follow-up study. 
In summary, the literature regarding prognostic models provides a diverse menu 
of research opportunities. Refinement of design has proceeded more rapidly than 
implementation of prognostic models in clinical practice. Virtually all investigators 
engaged in this line of inquiry recommend testing in alternate settings to confirm 
generalizability of the model. However, it is unknown whether these predictive models 
are routinely used in practice after the research study. Many research instruments are 
created to meet specific clinical needs, yet are not implemented systematically, or 
evaluated for long-term utility and ease of use. The next section of the literature review 
addresses the significance of structure and process in adding to the value of prognostic 
models. 
Quality Health Outcomes Model 
The Quality Health Outcomes Model (QHOM) was originally described by 
Mitchell, et al. in 1998 and was a refinement of Donebedian's quality framework. The 
main elements of this classic quality model are structure, process and outcomes. Many 
healthcare organizations have used this model as the basis for quality programs. Rather 
than one element of Donebedian's framework producing a change in another, the QHOM 
reflects a dynamic, interrelated system that flows in many directions, and whose elements 
all affect each other. A unique feature of the QHOM is the lack of direct flow between 
interventions and outcomes (see Figure 2.6). 
Figure 2.6 
Quality health outcomes model. (Mitchell, P., Ferketich, S., Jennings, B., 1998) 
Several investigators have used the QHOM as a framework for nursing research 
design. Radwin and Fawcett (2002) approached model integration in a unique way. With 
the aid of a theoretician (Fawcett), Radwin retrospectively reviewed her own previous 
studies on disparate topics and retrofitted the QHOM into the research design. The 
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researcher concluded that the model was a good fit for her program of research (p. 360). 
The model was incorporated into a proposed study and several other future studies were 
designed to examine different constructs of quality oncology nursing care. 
This application of the QHOM is relevant to the study described here. 
Prognostication of mortality in the NH and subsequent goals of care discussions rely on 
the flow of information between the involved parties. Interventions will not necessarily 
result in the desired outcome; much depends on the interrelationship between patient and 
organizational characteristics as well as timing. 
Mayberry and Gennaro (2001) used the QHOM to describe using the QHOM 
framework for research and quality activities with second-stage labor patients. The 
interdisciplinary nature of the setting and multiple possible outcomes from the labor were 
explained clearly with integration of the model into nursing practice. The 
interrelationships between the patient, system, interventions and outcomes provided ideas 
for future research studies. The authors concluded that research studies based on the 
QHOM have the ability to influence health policy in the future. 
Chapter Three 
METHODOLOGY 
The purpose of this study was to examine the survival of a cohort of nursing home 
residents and to determine whether the MDS-CHESS scale accurately predicts mortality 
within six months after admission to a nursing home. This chapter provides a description 
of the research design, sample and sampling, instrumentation, data collection procedures 
and data analytic techniques. The protection of human subjects is also discussed. 
Research Design 
This retrospective correlational cohort study was conducted to examine mortality 
in residents of two nursing homes (NH) in southern California. Retrospective design is 
useful when working with large national sample, as the data has already been collected 
and can be accessed at any given point in time. Publicly reported data, such as that in the 
Minimum Data Set (MDS) database also allows evaluation of a construct at time intervals 
to determine selected endpoints. Additionally, with large samples, a representative 
sample of the population is more likely, as is adequate power for the study. Of added 
benefit, this type of research lends itself to addressing nursing concerns. The sample for 
this study was derived from two NH that are situated within the same comprehensive 
healthcare organization. The rationale for selecting organizationally-linked NH is to have 
the ability to determine variance among the cohorts if possible, given that they are 
governed by identical regulatory and procedural rules. Understanding any differences 
may be of benefit in future intervention studies. 
52 
53 
Sample and Sampling 
Data was obtained from the MDS 2.0 database, which is the federal database for 
NH that was first implemented in 1991, becoming a computerized process in 1998. 
Version 2.0 is an upgrade of the original software that contains modifications that support 
data analysis by making assessment items less ambiguous. Hawes et al. (1995) conducted 
reliability testing of the MDS in an effort to, " . . . enhance the reliability of the MDS, 
[provide] the results of the final reliability testing of the MDS items, and [discuss] the 
usefulness of the MDS in research efforts" (p. 173). 
The items of the MDS-CHESS subscale were compared to actual mortality rates 
to determine the accuracy of the scale in predicting death within six months of admission 
to a nursing home. The sample was comprised of all residents admitted to two NH 
facilities, who had an admission RAI submitted to the MDS during the calendar year 
2005. Working with a large national data set is advantageous when using a study design 
that includes multivariate analyses (Zeni & Kogan, 2007). 
The sample for this study was taken from the MDS database of nursing homes 
that receive Medicare reimbursement. The sample was derived from all residents over 65 
years of age that were admitted to two LTC facilities in a large urban area in the 
southwestern United States during the calendar year 2005. The advantage of this 
sampling method is that it is theoretically convenient and accessible, with less risk of 
missing data and adequate power. The disadvantage of this sampling method is that the 
data may be skewed by atypical LTC residents, such as post-acute residents who had a 
short-term stay in the NHs for rehabilitation after hospitalization. No published studies 
were found that derived the sample from less than several thousand subjects and multiple 
nursing homes. 
The sample consisted of NH residents with completed MDS admission 
assessments during the calendar year 2005. Data on mortality was also collected during 
the time period of 2005-2006. In this study, the completion of the first Resident 
Assessment Instrument (RAI) was compared to the death date. Because a discharge from 
the NH is not necessarily linked to death, this study required alternate methods of 
determining whether a resident was, in fact, still alive. Residents may die in a hospital, be 
transferred to another jurisdiction, or may survive beyond the end of the data collection 
period. From previous studies on death in NHs, it is expected that some residents would 
be unaccounted for, and would have to be eliminated from the study sample. To gather 
accurate mortality data, Medicare claims data was collected to determine date of death. 
Regardless of the setting in which a Medicare beneficiary died, a date of death can be 
linked to Medicare claims. 
Power, Effect and Sample Size 
In order to determine significance of statistical results, one must have an adequate 
sample size and minimize the possibility of " . . . drawing the wrong conclusion . . . with 
an errors of inference" (Munro, 2005). The chance of making a type I error is minimized 
by setting an adequate alpha level, or level of significance (Munro, p. 88). For this study, 
the significance level was set at 0.05; p-values less than or equal to the alpha level are 
considered statistically significant. Power is defined as the probability of detecting a 
difference or relationship if such a difference or relationship exists (Munro, p. 92). 
Providing adequate power in the sampling decreases the chance of making a type II error. 
A power of .80 has been chosen as an adequate level to prevent this error (Munro, p. 
100). Effect size was set at 0.5 for this study to determine the magnitude of the influence 
of the independent variable on the dependent variable. Using the power table provided in 
Hinkle, Weirsma and Jurs (2000), a minimum sample size of 155 was required for this 
study for correlation testing. 
In logistic regression, however, an estimate of the probability of a certain event 
occurring is made, rather than detecting the difference or relationship that may be 
present, such as in linear regression. No assumptions are made about the DV and IV, the 
relationship is non-linear, and is not normally distributed (Munro, 2005). In linear 
regression, the significance level is usually set at 0.05., as was the case in this study. P-
values less than or equal to the alpha level are considered statistically significant. 
Inclusion and Exclusion Criteria 
Inclusion criteria were residents over the age of 65 who had an admission 
Resident Assessment Instrument (RAI) completed in the MDS database sometime in 
calendar year 2005, and who died between June 30, 2005, and June 30, 2006. Exclusion 
criteria were residents under age 65 and those without a date of death in the Medicare 
claims database. 
Data Collection Procedures 
Although aggregate Medicare claims and patient care information is considered to 
be publicly reported and accessible in the United States, the information is not readily 
available to the general public through visitation to an internet web site or other direct 
methods. In order to collect data using one of the Medicare data sets, an investigator must 
progress through several phases of development, assisted by two agencies designated by 
the federal government to prepare the data request and create the data files. This section 
of the paper describes data collection procedures implemented by the investigator to 
obtain MDS data, and the phases of development the accompanied the data collection 
procedures. 
The Research Data Assistance Center (ResDAC) specializes in the "conversion of 
raw data into usable data sets" and assists the investigator to understand "Medicare and 
Medicaid program policies and coverage issues" 
(http://resdac.umn.edu/aboutus/resdac services.asp#free, 2008). Their services are 
essential in determining which data files and variables to request, and whether additional 
data is needed from another source. ResDAC staff assisted the investigator to create the 
data request and complete the necessary documentation to submit to the CMS Privacy 
Board. The purpose of the CMS Privacy Board is to ensure that data requests are for the 
purpose of improving the quality of care or decreasing costs for Medicare beneficiaries, 
and that there are adequate safeguards for protected health information (PHI) after receipt 
by the investigator. For this study, MDS assessment and demographic data was 
requested, as well as mortality data. Assessment data was required from January to 
December, 2005, and mortality data from June, 2005 to June, 2006. Because not all of the 
NH residents died during their stay at the two facilities, information across the continuum 
of care was needed. CMS contracts with another agency to provide access to beneficiary 
data across the care continuum. 
The Chronic Conditions Warehouse (CCW) was created in response to the 
Medicare Modernization Act of 2003, as part of the CMS plan to ". . . improve the 
quality of care and reduce the cost of care for chronically ill Medicare beneficiaries" 
(http://www.ccwdata.org/about.php. 2008). Assessment and claims data on chronic 
illnesses are collected and linked by a unique beneficiary identification number, which 
allows analysis of care across the continuum. The Iowa Foundation for Medical Care 
(IFMC) contracts with CMS to establish and maintain the CCW. Assessment and claims 
data on 21 chronic conditions is collected at the CCW, and custom data requests are also 
completed on an individual basis. 
A custom request was submitted for this study and the IFMC created data files in 
SAS software once the CMS Privacy Board approved the data request and payment was 
received. A CD-ROM containing compressed, encrypted data files was mailed to the 
investigator. A separate electronic communication was sent from IFMC containing 
decryption instructions and a secure password for accessing the data files. Support files, 
such as a user's manual, were also included on the CD-ROM. Technical support from 
IFMC was available throughout the data transfer and analysis process. 
Another feature of acquiring data from a federal database that is worthy of 
discussion are the distinct phases of progress identified by the investigator. Phase One 
involves knowledge acquisition regarding the components and syntax of that particular 
database. In this study, knowledge of the MDS instruments and terminology was acquired 
over a period of several months as data request documents were completed. Previously 
published studies provided valuable information regarding data elements included in the 
sample and related terminology. Without prior working knowledge of the MDS 
instruments and Medicare claims terminology, the learning curve was steep and 
necessitated multiple reference sources to dialogue with support staff. 
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Phase Two was characterized by identification of potential barriers from the 
technological perspective, such as availability of computer hardware considered to be 
secure by the CMS Privacy Board. For example, plans to place the study data on an 
organizational network such as a hospital system or university had to include detailed 
descriptions of Information Technology (IT) security at a level unknown to the average 
user. Discussions with the IT Security Officer at the healthcare system for the two NH 
revealed that additional security measures for the organizational network would have 
been necessary in order to meet the required CMS standards. This barrier was overcome 
by the decision to locate the data on an independent computer system without internet 
access in the investigator's home. The password-protected computer met the CMS 
security standards, as the risk of computer hacking and obtaining access to PHI was 
negated by lack of internet access. 
Phase Three of the data collection process was that of data acquisition and 
delivery from the IFMC. Adequate time must be allotted for data request review by the 
CMS Privacy Board, receipt of payment by CMS and delivery of the data files. This may 
involve four to six months from submission of data request documents. This timeline 
must be carefully considered to coordinate with other activities such as grant submission, 
study funding, and availability of support staff. For this study, approval of the data 
request was delayed for several months due to the volume of requests to the CMS Privacy 
Board. In summary, knowledge of data documentation requirements, familiarity with 
requested data elements and adequate time for approval of the data request must be 
carefully considered throughout the research process. 
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Data Analysis 
Hirdes, Frijters and Teare (2003) suggested in their original study on the MDS-
CHESS scale, that validity of the instrument be evaluated in an alternate setting that 
includes stable LTC residents. The original study was conducted in a Canadian Chronic 
Care (CCC) hospital, where the residents had complex and somewhat acute needs, unlike 
the typical American NH resident. The prognostic value of the scale was demonstrated in 
the CCC population. Prognostication is inherently difficult, and existing instruments can 
have a substantial variance with actual mortality rates. A validated screening tool that 
accurately predicts mortality in NH residents can assist the clinician to quickly evaluate a 
patient's burden of illness during an acute health crisis and guide discussion regarding 
goals of care. The ability to evaluate the crisis within the context of the individual's 
overall health can be an important part of decision making regarding goals of care and 
treatment. 
Dependent Variable 
The dependent or outcome variable in this study was mortality. Specifically, the 
evaluation measured the point in time from completion of the RAI (upon admission to the 
NH in 2005) to six months in the future. This measurement occurred within the confines 
of the 2005-2006 calendar years for these two LTC facilities. Therefore, the outcome 
(death) could have occurred anywhere from June 30, 2005 to June 30, 2006. 
Independent Variables 
Descriptive statistics were computed on the demographic variables of age, gender, 
and ethnicity. The MDS-CHESS instrument consists of nine items from the MDS RAI, 
and was used to analyze: Do-Not-Resuscitate (DNR), daily pain, parenteral I.V. access, 
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I.V. medications, oxygen, suctioning, any physician visit in the last two weeks, any 
physician change order in the last two weeks, and any abnormal lab values in the last 90 
days. Using the definitions provided below the MDS nurse entered assessment items 
according to documentation requirements. 
• DNR Order - in the event of respiratory or cardiac failure, the resident, family , or 
legal guardian has directed that no cardiopulmonary resuscitation (CPR) or other 
life-saving methods will be used to attempt to restore the resident's respiratory or 
circulatory function; either present or absent in the medical record. 
• Daily Pain - any type of physical pain or discomfort in any part of the body; either 
present or absent. 
• Parenteral or Intravenous (I.V.) access - device to permit intravenous 
medication or nutritional support delivery; either present or absent in the last 
seven days. 
• I.V. medications - any drug or biological given by intravenous push or drip 
through a central or peripheral port. Does not include heparin or saline flush to 
keep a heparin lock patent but does include epidural and intrathecal pumps and 
total parenteral nutrition (TPN). This item does not include I.V. medications 
administered only during dialysis or chemotherapy treatments. Item is either 
present or absent in the last 14 days. 
• Oxygen - continuous or intermittent oxygen via a mask, nasal cannula or other 
device; either present or absent in the last 14 days. 
• Suctioning - nasopharyngeal or tracheal suctioning is either present or absent in 
the last 14 days. 
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• Physician visits - any visit in the last 14 days by an MD, DO, podiatrist or dentist 
who is either the primary Physician or Consultant; also includes authorized 
Physician Assistant, Nurse Practitioner, or Clinical Nurse Specialist working in 
collaboration with the Physician, and excludes Medicine Men and licensed 
Psychologists. An examination described by this coding may be a full or partial 
exam at the facility or in the Physician's office, or an unscheduled examination by 
an Emergency Room Physician, for which frequency is recorded in the last 90 
days. The actual number of visits is documented. 
• Physician change orders - any orders for new or altered treatment in the last 14 
days by an MD, DO, podiatrist or dentist who is either the primary Physician or 
Consultant; also includes authorized Physician Assistant, Nurse Practitioner, or 
Clinical Nurse Specialist working in collaboration with the Physician. Orders 
include telephone, fax, or consultation orders, even those new or altered orders 
given on the day of admission that fall outside of standard admission orders. The 
number of days on which Physician orders were changed is recorded. 
• Abnormal lab values - any lab values that are abnormal when compared to 
standard values that are recorded in the last 90 days or since admission to the 
nursing home. This item includes abnormal fingerstick glucose values and is 
either present or absent. 
MDS assessments have been validated in numerous studies since its inception, 
and a variety of research studies have been conducted since that time (Fredericksen, 
Tariot & De Jonghe, 1996; Hawes et al., 1991, 1995, & 1997; and Morris et al., 1990). 
Items for the MDS-CHESS scale were derived from the MDS RAI, which is completed 
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within 14 days of admission to the NH, quarterly, annually and when changes in clinical 
condition occur. The MDS-CHESS items were identified from ". . . bivariate analysis of 
their relationships with mortality in the proportional hazards model" (Hirdes, Frijters, & 
Teare, 2003). Items that met an acceptable hazard ratio were included in the model and 
were validated to measure independent constructs. Since the MDS-CHESS items were 
validated in the original study, the analysis in this study focused on determination of 
whether the scale was an appropriate instrument to predict mortality in the two sample 
nursing homes. 
Descriptive and multivariate statistics were calculated to perform a secondary data 
analysis. Demographic variables such as age, gender and ethnicity were used to create a 
profile of the sample using descriptive measures. Age, sex and ethnicity were compared 
to mortality and items on the MDS-CHESS scale and are reported as an aggregate. 
Interestingly, age and Do-Not-Resuscitate status were not correlated with six-month 
prognosis in the original study (Hirdes, Frijters & Teare, 2003). 
Several statistical approaches were utilized to analyze the data. Correlational 
statistics were computed to determine relationships among and between the IVs and DV. 
Logistic regression statistics provided information about the predictive model and how 
well it fit with the sample. Multicollinearity was analyzed to ensure that variables were 
measuring different constructs. A demographic profile was created using descriptive 
statistics. 
The Pearson r correlation coefficient was used to determine the index, or strength, 
and direction of relationships between the IVs and DV (Hinkle, Weirsma & Jurs, 2003). 
The correlation coefficient (r) can range from +1.00 to -1.00, indicating a positive or a 
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negative (inverse) relationship. A value of 0.00 indicates no relationship exists. The 
strength of the relationship can range from .00-.25 (little, if any relationship) to .90-1.00 
(very high relationship). The strength of the relationship is also evaluated with a two-
tailed level of significance test at the 0.05 and 0.01 levels, which is reflected in the p-
value (p. 245). The p-value is an indication of the probability that the relationship (r) 
occurred by chance (p. 249). A Spearman rho was used to analyze relationships between 
the variables, and is similar to the Pearson r. This is useful to analyze curvilinear 
relationships, in which Pearson r may underestimate the strength of the relationship. 
While Pearson r requires interval or ratio level data; Spearman rho requires only ordinal 
data, and is based on the rank order of the values, rather than on the values themselves 
(http://www.sfu.ca/~richards/Zen/Pages/Chapl8.htm, 2008). All correlational statistics 
were computed using SPSS 14.0 Graduate software. 
Binary logistic regression analysis was conducted to determine the relationship 
between each IV and the DV, and therefore, the predictor ability of each IV on the DV. 
Logistic regression is a useful and appropriate analytic strategy for this study because of 
the ability to predict the effect of the IV on the DV, as well as the flexibility of using any 
level of measurement (Munro, 2005). Mertler and Vannata (2005) note that logistic 
regression techniques can analyze predictor variables of all types - continuous, 
categorical or dichotomous. Like discriminant analysis, logistic regression can classify 
subjects into groups, or predict group membership from a probability of zero to one, but 
does so without the assumptions or linear nature of discriminant analysis (Mertler & 
Vannata, 2005). Values produced in logistic regression computations are positive, and 
can be considered probabilities of a particular outcome. 
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The SAS data files provided by the IFMC were converted into Excel spreadsheets 
and logistic regression was computed using R software (R Development Core Team, 
2008). When analyzing predictor variables, several methods can be employed to create 
the regression model. Since the predictive model already existed (the MDS-CHESS 
scale), stepwise, forward or backward entry methods were not used, because the IVs were 
previously identified in the original study. For the IVs that comprised the model, 
correlation coefficients were computed, and odds of death occurring versus not occurring 
were calculated to ascertain the predictability of each independent variable in the model 
(Mertler & Vannata, 2005). 
Munro (2005) describes the concept of relative risk as how many occurrences 
exist in the total number of occurrences calculated for several conditions (p. 305). The 
ability to estimate risk is related to predictability of the outcome. Calculating odds ratios 
for each IV is at least equivalent to relative risk in the logistic regression model (p. 305). 
Odds ratios less than " 1 " indicate a decreased risk of an outcome; values greater than " 1 " 
are reflective of an increased risk of the outcome (Katz, 2006). The confidence interval 
(CI) for the odds ratios demonstrate a reasonable range of values expected. A large CI 
indicates that the sample size may be too small for the analysis being conducted (p. 130). 
In this study, the odds ratios were calculated for each IV and adjusted for age, ethnicity 
and gender. 
Once it has been determined or confirmed which IVs contribute to the regression 
model, an evaluation of the overall predictive ability of the model is completed. The 
likelihood ratio statistic is computed to measure the overall model fit and is reported as a 
p-value for each IV, given the other predictors already in the model. When results 
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demonstrate significance (p < 0.05) for an IV in the regression model, then the Wald test 
is done to determine the significance that the IV has on the model when it is either 
present or absent (Katz, 2006). 
Data analysis was designed to either support or not support the prognostic utility 
of the MDS-CHESS scale and if so, whether it was equivalent to that which is noted in 
the original study. Alternately, results that do not support correlation between the MDS-
CHESS scale and mortality might still be of value in the care planning process. 
Additional discussion on this topic is included in Chapter Five. 
Human Subjects Protection 
In order to ensure the protection of each subject's freedom from intrinsic risk or 
injury, and to ascertain rights to privacy and dignity, a variety of human subject 
protective mechanisms was utilized in this study. Approval for the proposed study was 
obtained from the University of San Diego Investigational Review Board, and the 
Palomar Pomerado Health Investigational Review Committee. Since this retrospective 
study was conducted on medical records, no participant informed consent was required. 
CMS requires a thorough description of data management procedures in the Data 
Use Agreement (DUA), a required document for the data request. Since data analysis and 
results are performed and reported as an aggregate, no Social Security Numbers (SSN) 
were required. A unique beneficiary identification number permitted comparison of NH 
admission to date of death. With these safeguards, protection of individual health 
information was maximized. Data files were provided as compressed, encrypted files on 
electronic media, and computer security was approved by CMS prior to the provision of 
data to the investigator. 
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In this chapter, study design was explored with rationales for sampling and 
determination of power, effect and sample size. An extensive outline of data collection 
procedures was given to provide readers with an overview of steps for consideration in 
future studies. Data analysis procedures were described with a brief explanation of 
statistical tests used for correlation and logistic regression. Results of the analysis will be 
discussed in the Chapter Four. 
Chapter Four 
STUDY RESULTS 
The purpose of this study was to determine survival rates of a cohort of NH 
residents and to determine whether the MDS-CHESS scale accurately predicts mortality 
within six months. The assessment items from the MDS that comprise the MDS-CHESS 
scale are DNR orders, daily pain, presence of parenteral IV line, IV medications, oxygen 
use, suctioning, physician visits in the two weeks prior to assessment, any physician 
change order in the last two weeks prior to assessment, and abnormal lab values. The 
presence of these items in the resident's assessment was evaluated for prediction of 
mortality. Other covariates were age, gender and ethnicity. In this chapter, study results 
will be presented. First, a descriptive profile of the sample will be presented, followed by 
the results specific to the research questions. 
Sample Characteristics 
The dataset provided by the Iowa Institute for Medical Care (IFMC) contained 
multiple assessment entries, so only admission assessments were used to look forward in 
time to date of death. After eliminating subjects that did not meet the inclusion criteria, 
the sample of 212 was further reduced by including only those over 65 years of age who 
had a death date and those who did not from both facilities. The final sample used for 
analysis was 191 residents. During the study period, 42 residents from Nursing Home A 
died, and 39 residents from Nursing Home B died. 
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The mean age of the sample was 82.35 years, with a standard deviation of 7.04 
years, ranging from 65-98 years; 34.5% of the sample (N=66) were male and 65.5% 
(N=125) were female. The majority of the sample was Caucasian (91.1%, n=174), 
followed by Asian/Pacific Islander (4.2%, n=8), Hispanic (3.1%, n=6) and African 
American (1.6%, n=3). Table 4.1 summarizes the demographic profile of the sample. 



















Pacific Islander 5 (4%) 
Black 2 (1%) 
Hispanic 4 (4%) 
Caucasian 99 (91%) 








Pacific Islander 3 (4%) 
Black 1 (1%) 
Hispanic 2 (3%) 
Caucasian 75 (92%) 
No significant differences were found between the two NH related to age with One-Way ANOVA (p=.479) 
Descriptive Findings 
The primary focus of the study was to determine the accuracy and utility of the 
MDS-CHESS scale at the two nursing homes from which the sample was derived. 
Evaluation of the scale in a stable nursing home population can provide insight into 
future expectations of health decline and the need for interventions that decrease 
suffering and prolong the dying process. In this study, the intent was to evaluate the 
model against the population, rather than re-validation of the scale. 
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Aim #1 Determine the accuracy of the MDS-CHESS scale for predicting six-
month mortality in two American nursing homes. 
Frequencies were computed on the items comprising the MDS-CHESS scale. 
Less than 25% of residents in the sample experienced daily pain, used oxygen, had IVs, 
received IV medication, or were suctioned. Most residents had at least one Physician 
change order in the 14 days preceding the admission assessment, peaking at 17% (n=33), 
and 56 residents (29%) had Physician's visits in the two weeks preceding the assessment. 
Overwhelmingly, residents had abnormal lab values in the 90 days prior to the admission 
assessment. Only 57 (34%) had a DNR order in the medical record. Table 4.2 includes a 
summary of the MDS-CHESS variable frequencies and the predictor values for each IV. 
Because none of the predictor variables demonstrated significance, the Wald statistic was 
not computed. 
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Table 4.2 Predictor Variable Descriptives 
Variable Name ~~ 
Do Not Resuscitate 
0 (not present on chart) 
1 (present on chart) 
Pain Frequency 
0 (no pain) 
1 (pain less than daily) 



























1 (American Indian/Alaskan Native) 
2 (Asian/Pacific Islander) 
3 (African American) 
4 (Hispanic) 
5 (Caucasian) 







































a. The p-value is from the likelihood ratio test for testing the overall effect of the predictor. 
The null hypothesis is that the nine variables on the MDS-CHESS scale do not 
predict mortality in this sample of nursing home residents. Several statistical approaches 
were utilized to analyze the data including correlations and logistic regression. 
Correlations between the IVs and DV were performed in the original study, and were 
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repeated in this sample. Additionally, IVs were evaluated for multicollinearity to ensure 
that different constructs were being analyzed. Logistic regression was used to determine 
whether presence of the IV predicted the DV, death. The main outcome of this analysis 
was that 81 out of 191 residents (42.2%) died between June 30, 2005 and June 30, 2006. 
Correlation 
A correlation matrix was computed to determine the relationships between the 
IVs (DNR status, daily pain, IV access, IV Medications, oxygen use, suctioning, 
physician's change orders, physician's visits, and abnormal lab values), co-variates (age, 
gender, ethnicity and site) and the DV (death). Correlation coefficients demonstrate 
relationships between IVs, as well as the differences in variance of each IV that can be 
associated with variance differences in another IV (Hinkle, Weirsma & Jurs, 2003). 
Correlations between items on the MDS-CHESS scale were significant as noted in the 
Table 4.3, and demonstrated statistical significance in the p-values for each relationship. 
All correlations in Table 4.3 were positive, with the exception of DNR/suctioning, 
DNR/MD orders, and suctioning/abnormal labs, which were inversely related. 
Table 4.3 Pearson Correlation Coefficients of MDS-CHESS Variables 






MD visits/MD orders 




















Correlation is significant at the 0.05 level (2-tailed) 
^Correlation is significant at the 0.01 level (2-tailed) 
These data infer that although the relationships between certain variables are likely to be 
found in the population, they are not considered to be of substantial importance (Munro, 
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2005) in a predictive model. Spearman rho correlation coefficients were almost identical 
to Pearson r and are therefore, not reported in this chapter. No correlation or statistical 
significance was demonstrated between the DV (death) and any of the IVs, as shown in 
the Correlation Matrix. 














































































































































Correlation is significant at the 0.05 level (2-tailed) 
Correlation is significant at the 0.01 level (2-tailed) 
Collinearity 
Multicollinearity is a problem that can occur when there are moderate to high 
correlations between variables, indicating that they could be measuring the same 
construct (Merrier & Vanatta, 2005). Collinearity analysis is evaluated by several 
measures, Tolerance and the Variance Inflation Factor (VIF), which are analyzed as part 
of the regression procedure. Generally, if there is a high tolerance, only a small 
percentage of the variance in a variable is shared wit the other predictors (p. 288). In this 
study, oxygen use (PI AG) shares 25% variance with other predictor variables; suctioning 
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(P1AI) shares 31% variance with other predictor variables. Physician's Visits (P7) and 
Physician's Change Orders (P8) share 28% and 33% of variance respectively, with other 
predictor variables. Because the Inflation Factors remain small for these predictor 
variables and the Tolerance values all exceed 0.1, multicollinearity is not a problem, as 
shown in Table 4.5 below. 
















































a Dependent Variable: death 
Note: Constant VI is unique beneficiary number assigned to each set of assessment variables. Site denotes 
one of the two long-term care facilities. Neither are predictor variables. 
Logistic Regression 
Logistic regression was then computed to determine which of the IVs affected the 
probability of the outcome, death (Munro, 2005). The sample analyzed was 191 subjects, 
which provided enough power to reduce the chance of a Type I error in linear regression 
calculations. However, in logistic regression, power is less important than the relative 
risk of a particular outcome occurring. Relative risk is evaluated by computation of Odds 
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Ratios (OR) with the desired Confidence Interval (CI). Bivariate association between 
each IV and the DV were analyzed with the likelihood ratio test, which compares 
observed to predicted values and determines significance (p. 307). Although none of the 
variables achieved statistical significance, it is difficult to draw any conclusions from the 
statistics. Lack of significance could be due to the number of variables in the model -
nine predictive variables and four demographic variables. Mertler and Vannata (2005) 
caution investigators regarding limiting the ratio of cases to predictor variables to ensure 
that an adequate sample is analyzed to demonstrate significance. One of the features of 
analyzing a data set from an administrative database is that there will be missing data, for 
which subjects must be excluded in the sample. Once the missing and inaccurate data had 
been removed from the data set, too few beneficiaries remained in the sample for the 
number of variables being tested. 
Aim #2: Determine whether there are differences in six-month post-admission 
mortality between two NH populations operated under identical regulatory and 
organizational rules. 
The logistic regression model was analyzed with all the predictor variables, 
demographics and the SITE variable to determine differences between the two facilities. 
The only predictors that approached statistical significance were IV medication use and 
ethnicity. Those who were administered IV medications had a higher risk (OR=2.26, 
95%CI 0.97, 5.28) of dying than those who did not. African Americans were more likely 
to die (OR=18.16, 95%CI -1.12, 292.41) than American Indians and other ethnic groups. 
However, the wide CI (95%) for the odds ratio indicates small cell counts, which makes 
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this inference unreliable. Table 4.6 presents data computed from the regression analysis. 
The complete Logistic Regression Coefficients table is included in Appendix A. 
Table 4.6 Logistic Regression Analysis 
Variable Name 































































































a. Reference level of the categorical variable 
b. The p-value is from the likelihood ratio test for testing whether the predictor 
is significant given the other predictors were already in the model. 
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Summary of Results 
Results presented in this chapter were an analysis of correlation and logistic 
regression. None of the predictor variables were shown to be statistically significant in 
predicting the outcome of mortality, likely due to an inadequate number of cases per 
predictor variable. Logistic regression revealed that the overall model was not a good fit, 
which was supported by the results of the odds ratios. Further discussion of results and 
interpretation will be done in Chapter Five. 
Chapter Five 
DISCUSSION OF FINDINGS 
The purpose of this study was to retrospectively determine six-month mortality of 
a cohort of NH residents and the relationships between mortality and the variables 
comprising the MDS-CHESS scale. The sample was derived from a data set of Medicare 
beneficiaries who were admitted to two nursing homes in the calendar year 2005 which 
contained assessment and demographic information. The two nursing homes were part of 
a public healthcare system in southern California. One facility was free-standing and the 
other was located on the grounds of a hospital within the healthcare system. 
The original dataset for the two nursing homes of 238 subjects was decreased to 
212 subjects to eliminate duplicate beneficiary identification numbers. Of those 212 
subjects, 191 had death dates documented in the dataset. Since six-month mortality was 
the DV, only deaths that occurred between June 30, 2005 and June 30, 2006 were 
included in the analysis. The study sample was composed primarily of females with a 
mean age of 82.35 years. Most residents were Caucasian, followed by Asian/Pacific 
Islanders, Hispanics and African Americans. 
Of the NH 191 residents 65 years of age or over who died within the time interval 
of June 30, 2005 to June 20, 2006, 42 were in Nursing Home A (22%) and 39 were in 
Nursing Home B (20%). There was little difference in the mortality rates between the two 
nursing. Other studies have excluded hospital-based NH, as the post-acute population 
served there usually returns to home after rehabilitation from surgery, resulting in sample 
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bias. Both nursing homes studied are part of a larger healthcare organization that 
maintains continuity of care by discharging hospital patients to the nursing homes for 
post-surgical or functional rehabilitation. For this reason, mortality may actually be less 
than in a non-hospital-based nursing home. This could have attributed to the small sample 
size. 
The overwhelming majority of residents were Caucasian in both nursing homes. 
The ethnic profile of the sample does not reflect the ethnic profile of the geographic area 
in which the nursing homes are located. The San Diego Association of Governments 
(SANDAG) tracks and forecasts census, housing and economic data, which has been 
used for strategic planning by healthcare organizations, government, and other 
businesses. According to SAND AG (2008), 44% of the population in the geographic 
location of Nursing Home B is Hispanic, followed by Caucasian, then Asian. Nursing 
Home A is located is a geographic area in which Caucasians account for 74% of all 
residents, followed by 12% Hispanics, then 8% Asians. Differences in ethnicity among 
the residents are most likely due to the family caregiving practices of the ethnic 
subgroups evaluated. Asian/Pacific Islanders, Hispanics and American Indian/Alaskan 
Native populations typically do not admit family members to nursing homes, preferring 
to provide personal and health-related support within the home or community (Lipson & 
Dibble, 2005). This could account for the skewed ethnic mortality profile in the sample as 
compared to the geographic ethnic profile. 
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Aim #1 Determine the accuracy of the MDS-CHESS scale for predicting six-month 
mortality in two American nursing homes. 
The study sample included residents admitted to the two nursing homes in 
calendar year 2005. It is possible that some of the residents died more than or less than 
six months from admission to the nursing home, and therefore outside of the analyzed 
time period. Since survival rather than survival time was measured in the study, this 
should not have affected results. However, beneficiary death outside of the defined time 
frame (June 30, 2005 to June 30, 2006) could have resulted in a smaller sample size while 
confirming the overall prognostic ability of the model, though with a few calendar days 
difference. 
Studies that derive the sample population from large administrative databases 
have several advantages as described in Chapter Two, including the ability to 
retrospectively study large numbers of subjects and more efficiently evaluate outcomes of 
care. All databases potentially have missing data points for individual variables, 
excluding those subjects from analysis. Other reasons for excluding subjects are values 
with unusable codes and duplicate identifiers. Regardless of whether government-
controlled or private databases are utilized for a study, thorough understanding of the 
coding, definitions, variables and process for access cannot be underestimated. For many 
studies, a data manager is included in the study team for the purpose of cleaning the 
dataset prior to analysis. 
One of the challenges to acquiring the Medicare data used in this study was the 
process for obtaining the data set. Many revisions to the data request were submitted over 
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a period of five months before the data request was accepted for approval. A significant 
barrier was the taxonomy used for both the Medicare data and the data request process. 
Multiple communications with the contracted data management agencies were necessary 
to maximize mutual understanding of the specifics of the individual data request for this 
study. Investigators wishing to study some aspect of the continuum of care must have a 
basic understanding of tools and taxonomy of each database, as well as billing and 
documentation structure that ultimately influences data collection for any study of this 
type. 
Another challenge was that of estimating how much data to request. Admission 
assessments were requested from calendar year 2005, with mortality data from 2005 and 
2006. Despite adequate anecdotal admission volume, the study ultimately was 
underpowered after excluding unusable data. Maintaining focus on two nursing homes in 
the same healthcare organization could have been accomplished by requesting data from 
additional calendar years, rather than from 2005 only. Each additional year's data 
increases the cost of the data request, thus requiring some source of funding to complete 
the study. Thus, only one calendar year was requested. Previous studies of this design 
have been funded through grants and have support personnel such as data managers, or 
investigators in academic healthcare centers to ensure adequate support and expertise. 
Despite acquisition of an initial data file of over 2,200 subjects from the MDS database, 
many were excluded for reasons previously detailed, resulting in a sample of 191. 
All residents in the sample were evaluated for the presence of each of the nine 
variables in the MDS-CHESS scale, as well as three demographic variables and the site 
variable. While IV medications (p=.18) and ethnicity (p=.13) had the lowest/? value on 
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the likelihood ratio test, the two items did not meet the threshold for significance. Other 
items ranged from ^-values of 0.31 (Physician's orders) to 0.96 (daily pain) for the 
overall effect of each predictor. In the original study by Hirdes, Frijters and Teare (2003) 
significance of 0.001 was achieved on all scale items. It is possible that in a future study 
with additional calendar years included in the data set, statistical significance could be 
computed for the nursing homes in this study. 
Logistic regression was conducted to determine whether the statistical model 
derived from the MDS-CHESS scale fit the sample population. Bivariate analysis using 
the likelihood ratio test demonstrated the nine items that comprise the MDS-CHESS scale 
(DNR, pain, IV, IV meds, oxygen, suctioning, Physician's orders, Physician's visits, and 
abnormal labs) did not individually affect mortality, as evidenced by significance levels 
greater than 0.05 (range 0.06 to 0.98). Because of the overwhelmingly positive findings 
in the original study, there is reason to believe that with additional subjects, significance 
can be achieved with relation to the IVs predicting mortality. 
Aim #2: Determine whether there are differences in six-month post-admission 
mortality between two NH populations operated under identical regulatory and 
organizational rules. 
Initially, there was a desire to compare differences between the two nursing 
homes, and possibly to offer explanations for any differences in mortality rates or IVs. 
The relative importance of determining differences between two organizationally-related 
facilities has not been demonstrated in the literature. Rather, quality indices are used to 
benchmark sister organizations for ensure similar outcomes of care. Porock, et al., studied 
nursing homes in the state of Missouri as an aggregate (2005), with a sample size of over 
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40,000 NH residents. Recommendations from other investigators studying prognostic 
scales suggest determining accuracy of the scale variables in a homogenous population, 
or in a different geographic region. However, smaller sample sizes run the risk of not 
having enough power for statistical significance. Once the dataset was decreased to 
reflect only the inclusion criteria, the sample size was not powered to demonstrate 
significance in correlation analyses. Indeed, mortality rates were very similar between the 
two facilities. Of greater value to a healthcare organization would be to determine 
rehospitalization and/or Emergency Department visits for NH residents who have 
advanced illness and are positive for assessment items on one of the validated scales that 
predict mortality. 
Implications for Nursing 
Implications for Nursing Practice 
The first duty that healthcare providers have to patients is to do no harm. The 
concept of failure to rescue applies not only to patients who are receiving curative 
treatment, but also to patients who require aggressive management of symptoms related 
to their disease. As chronic diseases advances, the downward trajectory is somewhat 
predictable. Assessing for, correctly identifying and intervening when prognostic signs 
appear over time can be considered the prevention of harm and undesirable outcomes. 
Nurses place great value on physical and psychosocial support of patients and families, 
which positions the individual nurse to identify current Advance Directives, prepare 
patients and loved ones for transitions in health status, and ensure that physicians' orders 
are consistent with the patient's wishes. Participation in interdisciplinary team meetings 
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or patient care conferences provides an opportunity for the nurse to access information 
and resources for patients that may not have been made available in past interactions. 
Physicians are reluctant to prognosticate, and nurses may see this process as 
outside the scope of nursing practice. State Nurse Practice Acts are clear that medical 
prognostication is outside the realm of nurses. However, knowledge of research-based 
prognostic indicators for selected populations is certainly within acceptable nursing 
practice. Prognostic indexes for medical conditions or organ transplantation serve to 
activate a series of steps, or to evaluate candidacy for a procedure; these indexes or 
screens are used routinely by nurses to communicate information and implement 
previously established research-based protocols. 
Interdisciplinary Teams (IDT) function as forums to discuss plans of care and 
overall patient situations, and are consistent part of the structure of nursing homes, home 
health, hospice, and other specialized services. Practice implications from this study for 
nursing homes include using a prognostic scale in the evaluation of newly admitted 
residents, as well as disease-specific prognostic tools to alter the plan of care when 
warranted or desired by the resident or family. In home health, recognition of severity of 
prognosis can lead to front-loading home visits to prevent rehospitalization or emergency 
department visits. Additionally, the home environment may be more conducive to 
information gathering and referrals in the absence of a crisis-oriented hospitalization. 
Palliative care or hospice informational visits can provide a measure of comfort for 
patients and families who are at high risk of exacerbation of illness and subsequent 
suffering. The value of supporting family members who must provide caregiver services 
cannot be underestimated, as the caregivers often experience altered decision making 
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skills under duress. The previously mentioned sequelae of support can arise out of the 
nurse's knowledge of a realistic prognosis. 
Nursing Education 
Nursing academic curriculums have shown great improvement in educating 
students regarding EOL topics during the course of studies. Many hospital-based training 
programs also include EOL content in their orientation process. However, a significant 
missing element of EOL nursing education in all settings is discussion of the strategies 
necessary to communicate with physicians regarding patients' prognoses. Nurses are 
affected by the professional norms regarding prognostication that exist among physicians. 
These barriers were recently described Glare and Sinclair (2008) and consist of the 
following tenets: 
> Do not make predictions 
> Keep what predictions you make to yourself 
> Do not communicate predictions to patients unless asked 
> Do not be specific 
> Do not be extreme 
> Be optimistic 
Such covert directives are seldom effective and do not observe the right to self-
determination for patients, nor do they provide truly informed consent. Nurses play a key 
role in identifying crisis points at which direct communication about prognosis is 
necessary to prevent adverse outcomes or unwanted decisions about prolonging life. 
Education of experienced and novice nurses in eliciting information regarding 
what the future holds for specific patients can be compared to patients' and families' 
85 
perspectives to identify gaps in understanding that impede decision making. A related 
nursing education topic is the practical application of how to intervene during a short 
hospital stay versus intervention with a patient known throughout the illness trajectory. 
For shorter stay patients, key patient care areas that can benefit from additional training 
include the Emergency Department, Intensive Care, Step-Down/Intermediate Care, and 
Home Health, which are entry and exit points during crisis. Targeting nurses that work in 
these areas has the potential to interrupt the cycle of readmission and aggressive 
treatment in the advanced stages of illness. The ultimate goal would be the amelioration 
of suffering and psychosocial and spiritual support. 
For nurses familiar with patients because of repeated care episodes (e.g. oncology, 
long-term care, dialysis, neurological services), education may include methods that 
assist patients and families to adjust to transitions in the disease process. The 
relationships that are built with repeated care episodes engender trust and reassurance of 
support. Therefore, goals of care discussions may be perceived as less threatening and 
part of normal operations. Yet, even experienced nurses shy away from overt dialogue 
about prognostication, contributing to a collaboration of withholding the truth. 
Educational emphasis on discussing predictions about future health outcomes as a normal 
activity can only enhance communication between patients, families and healthcare 
providers. Additionally, education at networking forums with other palliative care and 
hospice providers also offer the opportunity to discuss the various prognostic scales and 
advantages of each. 
Finally, education on individualizing care discussions that recognize and honor 
cultural differences is gaining more priority throughout healthcare. Few hospitals, nursing 
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homes or other care settings have incorporated meaningful cultural sensitivity and 
competency into the workforce. Despite regulatory mandates to improve cultural 
competence, no easy solution for doing so has appeared. In the geographic region of the 
study, cultural differences account for much miscommunication and conflict among 
patients, nurses and physicians related to EOL care. Because of the different cultural 
compositions of healthcare providers and patient populations for each care facility, 
individual solutions must be identified, as well as educational approaches. A supportive 
strategy for engaging nurses and physicians in this learning dialogue is to embed cultural 
concepts into forums and processes in which treatment planning and ethical decision 
making occur. Nurses have the ability to change perspectives regarding the value of 
cultural awareness if they are educated on strategies for doing so. Too often, the influence 
of culture on treatment decisions and EOL care is devalued if patient/family opinions 
differ from those of the healthcare team, and is thought to be too complicated to explore, 
setting the stage for additional conflict. Many educational approaches are necessary to 
alleviate these perspectives and improve care. 
Nursing Research 
Implications for nursing research will be discussed from two perspectives, that of 
nursing at the sample organization, and nursing as a whole. Within the healthcare 
organization the two NH represent, a follow-up study could select and test use of a 
prognostic index to screen for mortality risk, and its correlation to actual referral to 
hospice or palliative care services. Currently, in palliative care the basic screening 
question is, "Would you be surprise if this patient died within the next year?" Using such 
minimal referral criteria produces the desired goals of care conversation, but does answer 
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the central question of uncertainty (estimated/predicted time until death), and prognosis is 
not speculated upon systematically. During IDT meetings at NH, a decision is made 
regarding when to rediscuss a resident at IDT. Sometimes rediscussions by the team are 
set months in the future if a resident is stable. Knowledge of prognostic indicators can 
alter the rediscussion schedule, and perhaps to detect increased frailty or clinical decline. 
A prospective trial to incorporate prognostic information for new admissions or regularly 
scheduled assessments could yield valuable insights regarding effects of bringing 
prognosis into open discussion. 
In nursing as a whole, future research studies should include the nurse's role, 
influence and comfort in participating in prognostic discussions, and the effects on 
providing quality EOL care in a variety of settings. Globally, nurses have different 
comfort and competency levels related to participating in patient care conferences. The 
phenomenological perspective of nurses distressed by care they provide to seriously ill 
patients is important, insofar as their personal viewpoint often influences the care and 
support that is provided to patients and families. This is never truer than when a patient's 
religious or cultural norms conflict with those of the nurse. Future research should 
explore methods of expanding understanding of conflict resolution within the scope of 
nursing practice, as well as how best to access and incorporate prognostic information 
into treatment decision making and support of patients, families and the entire healthcare 
team. 
Conclusion 
In this study, a previously validated prognostic scale was evaluated for accuracy 
in a sample of nursing home residents. Statistical analysis failed to demonstrate 
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significance for items on the MDS-CHESS scale for predicting mortality. In his 
sociological dissertation, Christakis (1995) stated that prognosis serves to ". . .organize 
clinical knowledge, [influence] conceptions of 'complications', and [order] diagnostic 
possibilities." In an effort to manage uncertainties of the future (p. 293). It has been well-
demonstrated that physicians often provide an overly optimistic prognosis to patients for 
a variety of reasons (Christakis & Lamont, 2000; Coventry, Grande, Richards & Todd, 
2005; Farquhar, Grande, Todd & Barclay, 2002). In a study by Christakis and Lamont 
(2000), physicians reported to investigators overly optimistic estimates of survival by a 
factor of five in patients newly admitted to hospice. This leads one to believe that even in 
the absence of emotional reactions from patients and families to the bad news, there is a 
large margin of error that cannot be attributed to characteristics of the physician or 
patient. 
Demystifying prognostication and educating physicians and nurses to use 
prognostic tools within the interdisciplinary team is likely to raise awareness of high-risk 
patients for whom a priority must be established to determine goals of care and advance 
directives. An important part of this education is the timing and style of communication 
used with patients and families. A cultural shift among healthcare disciplines is necessary 
to focus efforts on systematic methods of planning care for seriously ill individuals, and 
preventing harm that results when medical interventions contrary to goals of care are 
performed. 
Prognostication is essentially an attempt to gaze into the future and determine the 
best course of action for a given individual. Foreseeing and foretelling in healthcare can 
be thought of as ethical actions that are an attempt to provide a truthful picture of what 
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the future is likely to hold (Christakis, 1999). Both patients and physicians are reluctant 
to engage in or accept prognosis because of the perceived power of stating bad news as it 
relates to health. Instead, optimistic views of the future are provided if there are therapies 
that can alter the course of illness. This "ritualization of optimism" creates a barrier to 
ethical decision making and rationalizes the concept of futility for those with serious, 
advanced illness (p. 204-205). For seriously ill patients, the nature of their vulnerability 
obligates prognostic, as well as clinical and therapeutic responsibility (p. 210). 
This deeply affects nurses at different levels of awareness. An experienced nurse 
can speculate about prognosis due to knowledge of disease and treatment modalities. This 
seasoned nurse who is distressed by providing care deemed futile to patients with 
advanced illness may request an ethics committee consult. An essential element of ethical 
decision making (regardless of the model is used) is that of the patient's prognosis, which 
is often unclear in the medical record. For nurses wanting to facilitate communication 
between physicians and patients and families, this is a significant barrier. 
Knowledge of disease trajectories and prognostic indicators strengthens the 
professional role of the nurse in moderating perspectives that are often divergent. Novice 
nurses can be supported through feelings of moral distress in providing aggressive care to 
end-stage patients by establishing an accurate prognosis and through dialogue with 
patients and families about quality of life. None of these interventions is to be taken 
lightly, but serve the purpose of gaining knowledge of the individual patient, and 
advocating for their autonomy despite uncertainty of future outcomes. 
Just as there is a moral obligation of physicians to prognosticate as accurately as 
possible, there is a moral obligation of nurses to raise questions about the course of 
treatment as it relates to the presence of suffering, religious or spiritual concerns. 
Addressing concerns from a transcendent perspective becomes essential when discussing 
the possibility of death or disability. Although all patients and families cannot tolerate 
dialogue of this nature, attempts must be made for ethical and moral reasons. Acute care 
nurses may be unable to know the outcome of their attempts to incorporate prognostic 
indicators into goals of care discussion; hospital stays are too short and patients move to a 
different location before the end result is known. In long-term care, however, NH 
residents may be observed until time of death or transfer to a hospital where they die. 
Communication within the IDT at NH usually notes the death of residents who are 
transferred to the hospital and subsequently die. For NH nurses and other members of the 
IDT, a self-calibration is possible regarding the accuracy of prognostication, hopefully 
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